{"SLR NAME":"The divergent protective effects of angiotensin-converting enzyme
inhibitors and angiotensin receptor blockers on clinical outcomes
of coronavirus disease 2019 (COVID-19): a systematic review and
meta-analysis","References":[{"title1":"Angiotensin?converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe <styled-content style="fixed-case" toggle="no">COVID?19</styled-content> infection in a multi?site <styled-content style="fixed-case" toggle="no">UK</styled-content> acute hospital trust","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy","References":[]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","References":[]},{"title2":"COVID-19 and the cardiovascular system","References":[{"title3":"Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome"},{"title3":"The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target"},{"title3":"Mechanisms of COVID-19-induced heart failure: a short review"},{"title3":"The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science"},{"title3":"Mechanisms of COVID-19 pathogenesis in diabetes"},{"title3":"Cardiac iron overload promotes cardiac injury in patients with severe COVID-19"},{"title3":"Sexual dimorphism in COVID-19: potential clinical and public health implications"},{"title3":"Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities"},{"title3":"The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects"},{"title3":"Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?"},{"title3":"Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference"},{"title3":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress"},{"title3":"Hamidi A and Olsson A K: Platelets, NETs and cancer"},{"title3":"Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"COVID-19 and Cardiovascular Disease: From Bench to Bedside"},{"title3":"A global meta-analysis of depression, anxiety, and stress before and during COVID-19"},{"title3":"COVID-19 With Stress Cardiomyopathy Mortality and Outcomes Among Patients Hospitalized in the United States: A Propensity Matched Analysis Using the National Inpatient Sample Database"},{"title3":"Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic"},{"title3":"COVID-19 and metabolic syndrome"},{"title3":"Association between social isolation and reduced mental well-being in Swedish older adults during the first wave of the COVID-19 pandemic: the role of cardiometabolic diseases"},{"title3":"Metabolic Syndrome: Updates on Pathophysiology and Management in 2021"},{"title3":"COVID-19, Myocarditis and Pericarditis"},{"title3":"Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets"},{"title3":"Cardiometabolic syndrome:an emergent feature of Long COVID?"},{"title3":"Risk factors for severe and critically ill COVID-19 patients: A review"},{"title3":"The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19"},{"title3":"Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19"},{"title3":"Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses"},{"title3":"Impact of sex and gender on COVID-19 outcomes in Europe"},{"title3":"Depression and Anxiety in Old Age during the COVID-19 Pandemic: A Comparative Study of Individuals at Cardiovascular Risk and the General Population"},{"title3":"Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2"},{"title3":"Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease"},{"title3":"Association of social relationships with incident cardiovascular events and all-cause mortality"},{"title3":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation"},{"title3":"Domestic violence against women and the COVID-19 pandemic: What is the role of psychiatry?"},{"title3":"Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases"},{"title3":"Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis"},{"title3":"Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review"},{"title3":"SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells"},{"title3":"Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews"},{"title3":"Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor"},{"title3":"COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors"},{"title3":"COVID-19 infection and its impact on case fatality in patients with pulmonary embolism"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Loneliness and social isolation as risk factors for mortality: a meta-analytic review"},{"title3":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases"},{"title3":"COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis"},{"title3":"Nationwide Analysis of the Outcomes and Mortality of Hospitalized COVID-19 Patients"},{"title3":"N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients"},{"title3":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease"},{"title3":"Cardiovascular manifestations and treatment considerations in COVID-19"},{"title3":"TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation"},{"title3":"Incidence and risk factors of myocarditis in hospitalized patients with COVID-19"},{"title3":"Vascular Endothelial Cell Biology: An Update"},{"title3":"ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management"},{"title3":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review"},{"title3":"SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2"},{"title3":"Incidence and long-term specific mortality trends of metabolic syndrome in the United States"},{"title3":"Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis"},{"title3":"COVID-19 and cardiovascular diseases"},{"title3":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders"},{"title3":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease"},{"title3":"Gender-based disparities in COVID-19 patient outcomes"},{"title3":"Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19"},{"title3":"Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients"},{"title3":"Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus"},{"title3":"TMPRSS2 activity may mediate sex differences in COVID-19 severity"},{"title3":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies"},{"title3":"Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19"},{"title3":"Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin"},{"title3":"SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity"},{"title3":"Metabolic Syndrome and Its Components in Patients with COVID-19: Severe Acute Respiratory Syndrome (SARS) and Mortality. A Systematic Review and Meta-Analysis"},{"title3":"Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury"},{"title3":"The Global Epidemic of the Metabolic Syndrome"},{"title3":"COVID-19 and cellular senescence"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"Endothelial Cell-Activating Antibodies in COVID-19"},{"title3":"COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19"},{"title3":"SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1"},{"title3":"Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19"},{"title3":"Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis"},{"title3":"Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician"},{"title3":"Identifying age- and sex-specific COVID-19 mortality trends over time in six countries"},{"title3":"SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility"},{"title3":"Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones"},{"title3":"The bi-directional association between loneliness and depression among older adults from before to during the COVID-19 pandemic"},{"title3":"Inflammation: Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis"},{"title3":"Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling"},{"title3":"Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality"},{"title3":"Acute Cardiac Events During COVID-19-Associated Hospitalizations"},{"title3":"SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes"},{"title3":"Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic"},{"title3":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition"},{"title3":"APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19"},{"title3":"Neutrophil extracellular traps in COVID-19. JCI"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators"},{"title3":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction"},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial"},{"title3":"2018 ESC/ESH Guidelines for the management of arterial hypertension"},{"title3":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC"},{"title3":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group"},{"title3":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group"},{"title3":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction"},{"title3":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study"}]},{"title2":"COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease","References":[{"title3":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Potential effects of coronaviruses on the cardiovascular system: a review"},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease"},{"title3":"The science underlying COVID-19: implications for the cardiovascular system"},{"title3":"Coronaviruses and the cardiovascular system: acute and long-term implications"},{"title3":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China"},{"title3":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Covid-19 in critically ill patients in the Seattle region - case series"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China"},{"title3":"Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China"},{"title3":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Acute myocardial injury is common in patients with covid-19 and impairs their prognosis"},{"title3":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis"},{"title3":"End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock"},{"title3":"First case of COVID-19 complicated with fulminant myocarditis: a case report and insights"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"An experimental model for dilated cardiomyopathy after rabbit coronavirus infection"},{"title3":"COVID-19-related myocarditis in a 21-year-old female patient"},{"title3":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?"},{"title3":"Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement"},{"title3":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options"},{"title3":"Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"},{"title3":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2"},{"title3":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects"},{"title3":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease"},{"title3":"Cardiovascular complications and short-term mortality risk in community-acquired pneumonia"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia"},{"title3":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study"},{"title3":"Mechanisms of cardiac and renal dysfunction in patients dying of sepsis"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study"},{"title3":"Treating oxidative stress in heart failure: past, present and future"},{"title3":"Harnessing CAR T-cell insights to develop treatments for hyperinflammatory responses in patients with COVID-19"},{"title3":"Description and proposed management of the acute COVID-19 cardiovascular syndrome"},{"title3":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Structural basis of receptor recognition by SARS-CoV-2"},{"title3":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry"},{"title3":"Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis"},{"title3":"COVID-19, ACE2, and the cardiovascular consequences"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats"},{"title3":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction"},{"title3":"Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2"},{"title3":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Drugs and the renin-angiotensin system in covid-19"},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection"},{"title3":"Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"}]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"COVID-19 and the cardiovascular system [published ahead of print]."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for Covid-19 infection? [published online ahead of print]."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2."},{"title3":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor [published ahead of print]."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Ang II (Angiotensin II) conversion to angiotensin-(1-7) in the circulation is POP (prolyloligopeptidase)-dependent and ACE2 (angiotensin-converting enzyme 2)-independent."},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis."},{"title3":"Renal ACE2 expression in human kidney disease."},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase."},{"title3":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy."},{"title3":"Counterregulatory actions of angiotensin-(1-7)."},{"title3":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure."},{"title3":"Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension."},{"title3":"Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease."},{"title3":"Classic and nonclassic renin-angiotensin systems in the critically ill."},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2."},{"title3":"The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice."},{"title3":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan."},{"title3":"Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis."},{"title3":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism."},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? [published ahead online]"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics [published online ahead of print]."},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure."},{"title3":"Angiotensin receptor antagonists: safety and tolerability profile."},{"title3":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)."},{"title3":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers."}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","References":[{"title3":"Clinical risks for development of the acute respiratory distress syndrome"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Epidemiology and outcome of acute respiratory failure in intensive care unit patients"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2:a new cardiac regulator"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2"},{"title3":"Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome"},{"title3":"Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis"},{"title3":"Male-female differences in fertility and blood pressure in ACE-deficient mice"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study"},{"title3":"Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia"},{"title3":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice"},{"title3":"Consequences of alteration in capillary permeability"},{"title3":"Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure"},{"title3":"PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide"},{"title3":"Hypoxia and angiotensin II infusion redistribute lung blood flow in lambs"},{"title3":"Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome"}]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","References":[{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Severe Acute Respiratory Syndrome (SARS) Epidemiology Working Group. WHO consensus document on the epidemiology of severe acute respiratory syndrome (SARS). (http://www.who.int/csr/sars/en/WHOconsensus.pdf, 2003)."},{"title3":"Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology"},{"title3":"Updating the accounts: global mortality of the 1918-1920 &quot;Spanish&quot; influenza pandemic"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"World Health Organization. Confirmed human cases of avian influenza A (H5N1), 7 September 2004. (http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2004_09_07/en/print.html, 2004)."},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Imai, Y. et al. The SARS-coronavirus receptor angiotensin coverting enzyme 2 protects from severe acute lung failure. Nature (in the press)."},{"title3":"Chemokine receptor trafficking and viral replication"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Human coronaviruses-a brief review"},{"title3":"ACE1 polymorphism and progression of SARS"},{"title3":"Analysis on the SARS-CoV genome of PUMC01 isolate"},{"title3":"Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation"}]},{"title2":"CogStack - experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital","References":[{"title3":"An emerging standard for health communications: The HL7 standard"},{"title3":"Standardization of health informatics-results and challenges"},{"title3":"Simplifying HL7 Version 3 messages"},{"title3":"Automatic annotation of medical records"},{"title3":"Towards comprehensive syntactic and semantic annotations of the clinical narrative"},{"title3":"Applying natural language processing toolkits to electronic health records - an experience report"},{"title3":"Two biomedical sublanguages: A description based on the theories of Zellig Harris"},{"title3":"Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: Current status and recent enhancement of an Electronic Mental Health Record-derived data resource"},{"title3":"A case study of the Secure Anonymous Information Linkage (SAIL) Gateway: A privacy-protecting remote access system for health-related research and evaluation"},{"title3":"The 100,000 Genomes Project Protocol v3, Genomics England. 2017. 10.6084/m9.figshare.4530893.v2. (from https://www.genomicsengland.co.uk/about-gecip/publications/)."},{"title3":"Moen H, Ginter F, Marsi E, Peltonen L-M, Salakoski T, Salantera S. Care episode retrieval: Distributional semantic models for information retrieval in the clinical domain. BMC Med Inform Dec Making. 2015; 15(S2)."},{"title3":"NLP-PIER: A Scalable Natural Language Processing, Indexing, and Searching Architecture for Clinical Notes"},{"title3":"The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: Development and descriptive data"},{"title3":"Kartoglu IE. Cognition: DB binary-to-text converter and pseudonymiser for clinical research. 2015. https://github.com/KHP-Informatics/Cognition-DNC."},{"title3":"Jackson R, Kartoglu I. A Open Pipeline for Masking Patient Identifiers in Electronic Health Records, The Farr Institute International Conference 2015. 2015."},{"title3":"Development and evaluation of a de-identification procedure for a case register sourced from mental health electronic records"},{"title3":"Automated concept-level information extraction to reduce the need for custom software and rules development"},{"title3":"An Overview of the Tesseract OCR Engine"},{"title3":"Negation's Not Solved: Generalizability Versus Optimizability in Clinical Natural Language Processing"},{"title3":"Evaluating natural language processors in the clinical domain"},{"title3":"The unified medical language system (UMLS): Integrating biomedical terminology"},{"title3":"Neamatullah I, Douglass MM, Lehman L-wH, Reisner A, Villarroel M, Long WJ, Szolovits P, Moody GB, Mark RG, Clifford GD. Automated de-identification of free-text medical records. BMC Med Inform Decis Mak. 2008;8(1)."},{"title3":"MIMIC-III, a freely accessible critical care database"},{"title3":"University of Sheffield. KConnect UMLS Annotation Task. 2016. http://www.dcs.shef.ac.uk/~genevieve/kconnect/annotation-manual.pdf."},{"title3":"The Human Phenotype Ontology project: Linking molecular biology and disease through phenotype data"},{"title3":"A Simple Algorithm for Identifying Negated Findings and Diseases in Discharge Summaries"},{"title3":"Automatic concept recognition using the Human Phenotype Ontology reference and test suite corpora"},{"title3":"Annotating longitudinal clinical narratives for de-identification: The 2014 i2b2/UTHealth corpus"},{"title3":"Aamot H, Kohl CD, Richter D, Knaup-Gregori P. Pseudonymization of patient identifiers for translational research. BMC Med Inform Dec Making. 2013;13(1)."},{"title3":"Crown. Anonymisation: Managing Data Protection Risk Code of Practice, Infomation Commisioners Office. 2012. https://ico.org.uk/media/1061/anonymisation-code.pdf."},{"title3":"Biomedical data privacy: Problems, perspectives, and recent advances"},{"title3":"Fifty years' development and future perspectives of psychiatric register research"},{"title3":"Secondary use of EHR: Data quality issues and informatics opportunities"},{"title3":"Consequences of impaired data quality on information retrieval in electronic patient records"},{"title3":"Developing a new model for patient recruitment in mental health services: A cohort study using Electronic Health Records"},{"title3":"Improving performance of natural language processing part-of-speech tagging on clinical narratives through domain adaptation"},{"title3":"Domain adaptation for semantic role labeling of clinical text"},{"title3":"Automated systems for the de-identification of longitudinal clinical narratives: Overview of 2014 i2b2/UTHealth shared task Track 1"}]},{"title2":"Semantic computational analysis of anticoagulation use in atrial fibrillation from real world data","References":[{"title3":"Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study"},{"title3":"NICE. Atrial fibrillation: management (Aug 2014 update) [Internet]. 2014."},{"title3":"Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation"},{"title3":"A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation: The Euro Heart Survey"},{"title3":"The use of anticoagulants in the management of atrial fibrillation among general practices in England"},{"title3":"A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation"},{"title3":"Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD"},{"title3":"Risk of stroke and oral anticoagulant use in atrial fibrillation: A cross-sectional survey"},{"title3":"Big data from electronic health records for early and late translational cardiovascular research: challenges and potential"},{"title3":"The Value of Unstructured Electronic Health Record Data in Geriatric Syndrome Case Identification"},{"title3":"CogStack:Experiences of deploying integrated information retrieval and extraction services in a large National Health Service Foundation Trust hospital"},{"title3":"CogStack. CogStack Pipeline [Internet]. 2019. Available: https://github.com/CogStack/CogStack-Pipeline"},{"title3":"SemEHR: A general-purpose semantic search system to surface semantic data from clinical notes for tailored care, trial recruitment, and clinical research"},{"title3":"Wu H. CogStack-SemEHR [Internet]. p. 2019."},{"title3":"Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention"},{"title3":"Grouin C, Deleger L, Rosier A, Temal L, Dameron O, Van Hille P, et al. Automatic computation of CHA2DS2-VASc score: information extraction from clinical texts for thromboembolism risk assessment. AMIA. Annu Symp proceedings AMIA Symp. 2011;"},{"title3":"Personalized and automated remote monitoring of atrial fibrillation"},{"title3":"U.S. National Library of Medicine. Unified Medical Language System (UMLS) [Internet]. Available: https://www.nlm.nih.gov/research/umls/"},{"title3":"Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources"},{"title3":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study"},{"title3":"BioPortal: Enhanced functionality via new Web services from the National Center for Biomedical Ontology to access and use ontologies in software applications"},{"title3":"Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review"},{"title3":"Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT)"},{"title3":"Underuse of Oral Anticoagulation for Individuals with Atrial Fibrillation in a Nursing Home Setting in France: Comparisons of Resident Characteristics and Physician Attitude"},{"title3":"The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF Study"},{"title3":"Warfarin Treatment and All-Cause Mortality in Community-Dwelling Older Adults with Atrial Fibrillation: A Retrospective Observational Study"},{"title3":"Cardiovascular Registries: Too Much of Good Thing?"},{"title3":"Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation"},{"title3":"Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry"},{"title3":"High-performance medicine: the convergence of human and artificial intelligence"}]},{"title2":"MedCAT - medical concept annotation tool","References":[]},{"title2":"MIMIC-III, a freely accessible critical care database","References":[{"title3":"Adoption of Electronic Health record Systems among U.S. Non-federal Acute Care Hospitals"},{"title3":"NIH plans to enhance reproducibility"},{"title3":"Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC-II): A public-access intensive care unit database"},{"title3":"Standardizing clinical laboratory data for secondary use"},{"title3":"Observational Medical Outcomes Partnership Common Data Model. Website http://www.ohdsi.org/data-standardization/the-common-data-model/(Accessed: March 2016)."},{"title3":"Automated de-identification of free-text medical records"},{"title3":"Best practices for scientific computing"},{"title3":"MIMIC-III Critical Care Database: Documentation and Website http://mimic.physionet.org (Accessed: March 2016)."},{"title3":"PhysioBank, PhysioToolkit, and PhysioNet"},{"title3":"Dynamic data during hypotensive episode improves mortality predictions among patients with sepsis and hypotension"},{"title3":"Methods of Blood Pressure Measurement in the ICU"},{"title3":"Recent Advances in Clinical Natural Language Processing in Support of Semantic Analysis"},{"title3":"Combining structured and unstructured data to identify a cohort of ICU patients who received dialysis"},{"title3":"A 'datathon' model to support cross-disciplinary collaboration"}]},{"title2":"Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: the evalue package","References":[]},{"title2":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","References":[]},{"title2":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","References":[]},{"title2":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","References":[{"title3":"Physiology of local renin-angiotensin systems."},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"Pharmacologic modulation of ACE2 expression."},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2."},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19."},{"title3":"Renin-angiotensin system blockers and the COVID-19 pandemic."},{"title3":"Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients."},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China."},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19."},{"title3":"Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes."},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial."},{"title3":"Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure)."},{"title3":"Coronavirus emergency."},{"title3":"Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension."},{"title3":"Generating evidence from computerized healthcare utilization databases."},{"title3":"Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice."},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR."},{"title3":"A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costs."},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy."}]},{"title2":"Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study","References":[]},{"title2":"Should ethnicity serve as the basis for clinical trial design? Importance of race/ethnicity in clinical trials: lessons from the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","References":[]},{"title2":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy"},{"title3":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"ACE2 gene expression is up-regulated in the human failing heart"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions"},{"title3":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF"},{"title3":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Building bivariate tables: the compareGroups Package for R"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Renal ACE2 expression in human kidney disease"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Proteomics. Tissue-based map of the human proteome"},{"title3":"Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients"},{"title3":"Clinical relevance and role of neuronal AT"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease"}]},{"title2":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","References":[]}]},{"title1":"ReninAngiotensinAldosterone System Inhibitors and Risk of Covid-19","References":[{"title2":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","References":[]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19.","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling","References":[]},{"title2":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.","References":[{"title3":"Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association"},{"title3":"The role of ACE2 in cardiovascular physiology"},{"title3":"Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)"},{"title3":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS"},{"title3":"Myocardial infarction increases ACE2 expression in rat and humans"},{"title3":"ACE2 and AT4R are present in diseased human blood vessels"},{"title3":"Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor"},{"title3":"Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling"},{"title3":"Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease"},{"title3":"Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease"},{"title3":"Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications"},{"title3":"Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes"},{"title3":"N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery"},{"title3":"Nonobstructive coronary artery disease and risk of myocardial infarction"},{"title3":"2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)"},{"title3":"Third universal definition of myocardial infarction"},{"title3":"2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines"},{"title3":"Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease"},{"title3":"Circulating angiotensin-converting enzyme 2 activity in kidney transplantation: a longitudinal pilot study"},{"title3":"Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study"},{"title3":"Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions"},{"title3":"Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques"},{"title3":"Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis"},{"title3":"Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells"},{"title3":"Gene silencing of TACE enhances plaque stability and improves vascular remodeling in a rabbit model of atherosclerosis"},{"title3":"The ACE2 gene: its potential as a functional candidate for cardiovascular disease"},{"title3":"Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population"},{"title3":"Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort"},{"title3":"From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension"}]},{"title2":"Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.","References":[]},{"title2":"Combined antihypertensive therapies that increase expression of cardioprotective biomarkers associated with the renin-angiotensin and kallikrein-kinin systems.","References":[]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat.","References":[]},{"title2":"Losartan, a selective antagonist of AT1 receptor, attenuates acute lung injury induced by seawater inhalation in rats.","References":[]},{"title2":"Losartan attenuates ventilator-induced lung injury.","References":[]},{"title2":"Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats.","References":[]},{"title2":"Landiolol hydrochloride ameliorates acute lung injury in a rat model of early sepsis through the suppression of elevated levels of pulmonary endothelin-1.","References":[]},{"title2":"Esmolol attenuates lung injury and inflammation in severe acute pancreatitis rats.","References":[]},{"title2":"Heart disease and stroke statistics : 2019 update: a report from the American Heart Association.","References":[]},{"title2":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.","References":[]},{"title2":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.","References":[{"title3":"Characteristics of and important Lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72 314 cases from the Chinese Center for disease control and Prevention"},{"title3":"Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Recent Update of renin-angiotensin-aldosterone"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on short-Term mortality After sepsis: a population-based aohort study"},{"title3":"Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA"},{"title3":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway"},{"title3":"Beta Blocker and angiotensin-converting enzyme Inhibitor therapy Is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure"}]}]},{"title1":"ReninAngiotensinAldosterone System Blockers and the Risk of Covid-19","References":[{"title2":"Physiology of local renin-angiotensin systems.","References":[]},{"title2":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.","References":[]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin.","References":[]},{"title2":"Pharmacologic modulation of ACE2 expression.","References":[{"title3":"Angiotensin-converting enzyme II in the heart and the kidney"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Age-and gender-related difference of ACE2 expression in rat lung"},{"title3":"Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies"},{"title3":"Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system"},{"title3":"New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2:a potential target for treatment of hypertension and diabetic nephropathy"},{"title3":"ACE2 and the kidney"},{"title3":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice"},{"title3":"Developmental expression of ACE2 in the SHR kidney: a role in hypertension?"},{"title3":"ACE and ACE2 activity in diabetic mice"},{"title3":"Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes"},{"title3":"Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats"},{"title3":"Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats"},{"title3":"Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?"},{"title3":"Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease"},{"title3":"Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury"},{"title3":"Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy"},{"title3":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells"},{"title3":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients"},{"title3":"Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes"},{"title3":"Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway"},{"title3":"Co-localization of angiotensin-converting enzyme 2-, octomer-4-and CD34-positive cells in rabbit atherosclerotic plaques"},{"title3":"Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17beta-oestradiol regulation of renal pathology in renal wrap hypertension"},{"title3":"Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2"},{"title3":"ACE2 is preferentially localized in the tunica media layer in renal vasculature and its expression increases after administration of a type 1 receptor antagonist [abstract]"},{"title3":"Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat"},{"title3":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats"},{"title3":"Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors"},{"title3":"Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats"},{"title3":"Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats"},{"title3":"Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme"},{"title3":"Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat"},{"title3":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II"},{"title3":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice"},{"title3":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity"},{"title3":"Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property"},{"title3":"Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats"},{"title3":"ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes"},{"title3":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents"},{"title3":"Recombinant ACE2 attenuates angiotensin II induced hypertension [abstract]"}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases"}]},{"title2":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?","References":[{"title3":"Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID- 19 pandemic?"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension?"},{"title3":"Effects of sodium glucose co-transporter 2 inhibitors on the kidney"},{"title3":"Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats"},{"title3":"Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease"}]},{"title2":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19.","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"WHO Coronavirus (COVID-19) Dashboard"},{"title3":"Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Coronavirus disease 2019 case surveillance - United States"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) - China"},{"title3":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19"},{"title3":"Extrapulmonary manifestations of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target"},{"title3":"Preventing a COVID-19 pandemic"},{"title3":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?"},{"title3":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and risk of COVID-19"},{"title3":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China"},{"title3":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19"},{"title3":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: A prospective, randomised, open-label trial"},{"title3":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: A randomized clinical trial"},{"title3":"Effects of renin-angiotensin-aldosterone inhibitors on early outcomes of hypertensive COVID-19 patients: A randomized triple-blind clinical trial"},{"title3":"The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments"},{"title3":"Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews"},{"title3":"The cochrane collaboration's tool for assessing risk of bias in randomised trials"},{"title3":"Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2021. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp."},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis"},{"title3":"Effects of recent use of renin-angiotensin system inhibitors on mortality of patients with coronavirus disease 2019"},{"title3":"Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: A retrospective cohort study"},{"title3":"Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: A retrospective observational study"},{"title3":"Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension"},{"title3":"The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension"},{"title3":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea"},{"title3":"A retrospective study from 2 centers in China on the effects of continued use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with hypertension and COVID-19"},{"title3":"Impact of renin-angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: A retrospective observational study"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: A meta-analysis of observational studies"},{"title3":"Mortality and severity in COVID-19 patients on ACEIs and ARBs - A systematic review, meta-analysis, and meta-regression analysis"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: A living systematic review"},{"title3":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program"}]},{"title2":"Renin-angiotensin system blockers and the COVID-19 pandemic.","References":[{"title3":"Renin-Angiotensin-Aldosterone system inhibitors in patients with Covid-19"},{"title3":"Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults"},{"title3":"Mortality in COVID-19 patients treated with ACEIs/ARBs: Re-estimated meta-analysis results following the Mehra et al. retraction"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients"},{"title3":"Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: a systematic review and meta-analysis"},{"title3":"Angiotensin-Converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: systematic review and meta-analysis"},{"title3":"Renin-Angiotensin-Aldosterone system inhibitors and risks of severe acute respiratory syndrome coronavirus 2 infection"},{"title3":"Treatment with ACE inhibitors or Arbs and risk of severe/lethal COVID-19: a meta-analysis"},{"title3":"Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers"},{"title3":"Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension"},{"title3":"Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis"},{"title3":"A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: what is the evidence so far?"},{"title3":"Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID -19, inflammation level, severity, and death in patients with COVID -19: A rapid systematic review and meta-analysis"},{"title3":"Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Renin-Angiotensin system inhibitors and COVID-19: a systematic review and meta-analysis. Evidence for significant geographical disparities"},{"title3":"Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis"},{"title3":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis"},{"title3":"Renin-Angiotensin system blockade and mortality in patients with hypertension and COVID-19 infection"},{"title3":"A meta-analysis of the relationship between renin-angiotensin-aldosterone system inhibitors and COVID-19"},{"title3":"The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: a systematic review and meta-analysis"},{"title3":"The effect of prior angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment on coronavirus disease 2019 (COVID-19) susceptibility and outcome: a systematic review and meta-analysis"},{"title3":"ACEI/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis"},{"title3":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial"},{"title3":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19"},{"title3":"The reporting of studies conducted using observational Routinely-collected health data (record) statement"},{"title3":"Optum Labs: building a novel node in the learning health care system"},{"title3":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data"},{"title3":"2019 quality rating system (QRS) HEDIS value set directory 2019"},{"title3":"Past seasons estimated influenza disease burden"},{"title3":"Impact of renin-angiotensin-aldosterone system inhibition on mortality in critically ill COVID-19 patients with pre-existing hypertension: a prospective cohort study"},{"title3":"Angiotensin-Converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: a patient-level analysis of the PCORnet blood pressure control lab"},{"title3":"Renin angiotensin system blockers and risk of mortality in hypertensive patients hospitalized for COVID-19: an Italian registry"},{"title3":"Angiotensin-Converting enzyme inhibitor and angiotensin receptor blocker use associated with reduced mortality and other disease outcomes in US veterans with COVID-19"},{"title3":"Association of renin-angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study"},{"title3":"Characteristics associated with hospitalization among patients with COVID-19 : metropolitan Atlanta, Georgia, March-April 2020"},{"title3":"Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort Study"},{"title3":"Factors associated with COVID-19-related death using OpenSAFELY"},{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US"}]},{"title2":"Angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers and pneumonia risk among stroke patients.","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: interim guidance"},{"title3":"MERS, SARS and other coronaviruses as causes of pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for the risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans. Press release"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","References":[{"title3":"Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19"},{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Pathology and pathogenesis of severe acute respiratory syndrome"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC"},{"title3":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators"},{"title3":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction"},{"title3":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial"},{"title3":"2018 ESC/ESH Guidelines for the management of arterial hypertension"},{"title3":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC"},{"title3":"ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group"},{"title3":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group"},{"title3":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction"},{"title3":"Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study"}]},{"title2":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","References":[{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"COVID-19 and the cardiovascular system"}]},{"title2":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","References":[{"title3":"Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 States, March 1-30, 2020"},{"title3":"Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection"},{"title3":"Drugs and the renin-angiotensin system in covid-19"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study"},{"title3":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study"},{"title3":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality"},{"title3":"Coronavirus disease 2019 and hypertension: the role of angiotensin-converting enzyme 2 and the renin-angiotensin system"},{"title3":"Good ACE, bad ACE do battle in lung injury, SARS"},{"title3":"Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: implications for COVID-19"},{"title3":"Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure"},{"title3":"The expanding role of real-world evidence trials in health care decision making"},{"title3":"Real world evidence (RWE):are we (RWE) ready?"}]},{"title2":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.","References":[]},{"title2":"Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.","References":[]},{"title2":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.","References":[{"title3":"Phenotype and clinical outcomes of titin cardiomyopathy"},{"title3":"Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment"},{"title3":"Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes"},{"title3":"Heart failure with recovered ejection fraction: a distinct clinical entity"},{"title3":"Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long-term follow-up: does real healing exist?"},{"title3":"Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival: results from the valsartan heart failure trial"},{"title3":"Myocardial recovery and the failing heart: myth, magic, or molecular target?"},{"title3":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure"},{"title3":"Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies"},{"title3":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance"},{"title3":"A nomogram to predict exercise capacity from a specific activity questionnaire and clinical data"},{"title3":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology"},{"title3":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples"},{"title3":"Using high-resolution variant frequencies to empower clinical genome interpretation"},{"title3":"Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease"},{"title3":"Reduction in sample size for studies of remodelling in heart failure by the use of cardiovascular magnetic resonance"},{"title3":"Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol"},{"title3":"Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy"},{"title3":"Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy?"},{"title3":"Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators"},{"title3":"Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy"},{"title3":"Improved outcomes in peripartum cardiomyopathy with contemporary"},{"title3":"Shared genetic predisposition in peripartum and dilated cardiomyopathies"},{"title3":"Genetic etiology for alcohol-induced cardiac toxicity"},{"title3":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy"},{"title3":"Recovery of cardiac function in cardiomyopathy caused by titin truncation"},{"title3":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure"},{"title3":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial"},{"title3":"Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials"}]},{"title2":"Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).","References":[]},{"title2":"Coronavirus emergency.","References":[]},{"title2":"Early cardiovascular protection by initial two-drug fixed-dose combination treatment vs. monotherapy in hypertension.","References":[]},{"title2":"Generating evidence from computerized healthcare utilization databases.","References":[]},{"title2":"Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice.","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","References":[{"title3":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. Available from: https://www.who.int/health-topics/coronavirus "},{"title3":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological. [Accessed 21 Jan 2020]. Available from: http://virological.org/t/novel-2019-coronavirus-genome/319 "},{"title3":"de Groot RJ, Baker SC, Baric R, Enjuanes L, Gorbalenya AE, Holmes KV, et al. Family Coronaviridae. In: King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ. Virus taxonomy: classification and nomenclature of viruses: ninth report of the International Committee on Taxonomy of Viruses. London; Waltham: Academic Press; 2012. p. 806-20."},{"title3":"The severe acute respiratory syndrome."},{"title3":"World Health Organization. (WHO. Novel Coronavirus (2019-nCoV). Situation report - 1. Geneva: WHO; 21 Jan 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf "},{"title3":"SARS testing: First past the post."},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China."},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction."},{"title3":"Coordinated implementation of chikungunya virus reverse transcription-PCR."},{"title3":"Assay optimization for molecular detection of Zika virus."},{"title3":"Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences."},{"title3":"Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission."},{"title3":"Hosts and sources of endemic human coronaviruses."},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS."},{"title3":"Origin and evolution of pathogenic coronaviruses."},{"title3":"The European Virus Archive goes global: A growing resource for research."},{"title3":"Developing a framework to assess the costeffectiveness of COMPARE - a global platform for the exchange of sequence-based pathogen data."},{"title3":"Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018."},{"title3":"First international external quality assessment of molecular diagnostics for Mers-CoV."},{"title3":"Advancing preparedness for clinical research during infectious disease epidemics."}]},{"title2":"A new population-based risk stratification tool was developed and validated for predicting mortality, hospital admissions, and health care costs.","References":[]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy.","References":[]}]},{"title1":"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","References":[{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","References":[]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State.","References":[]},{"title2":"Seasonal influenza infections and cardiovascular disease mortality.","References":[{"title3":"Infectious burden and atherosclerosis: a clinical issue"},{"title3":"Influenza virus infection and risk of acute myocardial infarction"},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review"},{"title3":"Myocardial dysfunction during H1N1 influenza infection"},{"title3":"Global burden of influenza as a cause of cardiopulmonary morbidity and mortality"},{"title3":"Cardiac findings during uncomplicated acute influenza in ambulatory adults"},{"title3":"The cardiovascular manifestations of influenza: a systematic review"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Influenza-associated hospitalizations in the United States"},{"title3":"Excess mortality from causes other than influenza and pneumonia during influenza epidemics"},{"title3":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects"},{"title3":"Influenza and the winter increase in mortality in the United States, 1959-1999"},{"title3":"Forecasting seasonal outbreaks of influenza"},{"title3":"Real-time influenza forecasts during the 2012-2013 season"},{"title3":"How many illnesses does one emergency department visit represent? using a population-based telephone survey to estimate the syndromic multiplier"},{"title3":"Improving the estimation of influenza-related mortality over a seasonal baseline"},{"title3":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study"},{"title3":"Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database"},{"title3":"Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Recent respiratory infection and the risk of myocardial infarction"},{"title3":"Absolute humidity and the seasonal onset of influenza in the continental United States"},{"title3":"What weather variables are important in predicting heat-related mortality? a new application of statistical learning methods"},{"title3":"Effects of cold and hot temperature on dehydration: a mechanism of cardiovascular burden"},{"title3":"Estimates of deaths associated with seasonal influenza: United States, 1976-2007"},{"title3":"Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14"},{"title3":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010)"},{"title3":"Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic"},{"title3":"Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age"},{"title3":"Cardiovascular manifestations associated with influenza virus infection"},{"title3":"Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice"},{"title3":"Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide"},{"title3":"Association of influenza vaccination and reduced risk of recurrent myocardial infarction"},{"title3":"Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease"},{"title3":"Seasonal variations in coronary heart disease"},{"title3":"Seasonal variations in fibrinogen concentrations among elderly people"},{"title3":"Protein S declines during winter respiratory infections"},{"title3":"Plasma catecholamines and cardiovascular responses to cold and mental activity"},{"title3":"Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections"},{"title3":"An explanation for the seasonality of acute upper respiratory tract viral infections"},{"title3":"Effects of steam inhalation on nasal patency and nasal symptoms in patients with the common cold"},{"title3":"Local hyperthermia benefits natural and experimental common colds"},{"title3":"Syndromic surveillance in public health practice, New York City"},{"title3":"Mortality due to influenza in the United States: an annualized regression approach using multiple-cause mortality data"},{"title3":"During influenza season: all influenza-like illnesses are not due to influenza: dengue mimicking influenza"},{"title3":"Mortality associated with influenza and respiratory syncytial virus in the United States"},{"title3":"National and local influenza surveillance through Twitter: an analysis of the 2012-2013 influenza epidemic"}]},{"title2":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","References":[{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS"},{"title3":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases"}]},{"title2":"Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts","References":[{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"SARS-CoV-2: a potential novel etiology of fulminant myocarditis"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"Renin-angiotensin system in human coronavirus pathogenesis"}]},{"title2":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","References":[{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19"},{"title3":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors"},{"title3":"Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and prostate cancer susceptibility"},{"title3":"Cell entry mechanisms of SARS-CoV-2"},{"title3":"Tissue ACE phenotyping in prostate cancer"},{"title3":"Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells"},{"title3":"Clinical characteristics and results of semen tests among men with coronavirus disease 2019"},{"title3":"Role of proprotein convertases in prostate cancer progression"},{"title3":"Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells"},{"title3":"Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer"},{"title3":"Androgens and androgen receptor signaling in prostate tumorigenesis"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"The trinity of COVID-19: immunity, inflammation and intervention"},{"title3":"Epigenetic impact of infection on carcinogenesis: mechanisms and applications"},{"title3":"Prostate cancer and inflammation: the evidence"}]},{"title2":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.","References":[]},{"title2":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","References":[]},{"title2":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.","References":[{"title3":"The angiotensin II receptors"},{"title3":"Under pressure: the search for the essential mechanisms of hypertension"},{"title3":"The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease"},{"title3":"Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation"},{"title3":"New frontiers in the intrarenal Renin-Angiotensin system: a critical review of classical and new paradigms"},{"title3":"Niere und Kreislauf"},{"title3":"Studies on experimental hypertension. 1. The production of persistent elevation of systolic blood pressure by means of renal ischemia"},{"title3":"The preparation, purification, and amino acid sequence of a polypeptide renin substrate"},{"title3":"Characterization of human angiotensinogen"},{"title3":"Cloning and sequence analysis of cDNA for rat angiotensinogen"},{"title3":"The biological production of angiotensin"},{"title3":"The preparation and function of the hypertensin-converting enzyme"},{"title3":"Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme)"},{"title3":"Measurement of urinary kallikrein activity by kinin radioimmunoassay"},{"title3":"Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors"},{"title3":"The kallikrein-kinin system as a regulator of cardiovascular and renal function"},{"title3":"Active fragments of angiotensin II: enzymatic pathways of synthesis and biological effects"},{"title3":"Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors"},{"title3":"Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats"},{"title3":"Kidney aminopeptidase A and hypertension, part I: spontaneously hypertensive rats"},{"title3":"Structure-activity relationship in angiotensin analogs"},{"title3":"Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats"},{"title3":"AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats"},{"title3":"AT2 receptor activation induces natriuresis and lowers blood pressure"},{"title3":"Update on angiotensin AT2 receptors"},{"title3":"Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase"},{"title3":"Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors"},{"title3":"Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP)"},{"title3":"Angiotensin II receptors and functional correlates"},{"title3":"Angiotensin II receptors and angiotensin II receptor antagonists"},{"title3":"Angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli [corrected]"},{"title3":"Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor"},{"title3":"Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor"},{"title3":"Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors"},{"title3":"Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor"},{"title3":"Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition"},{"title3":"Cloning and expression of a novel angiotensin II receptor subtype"},{"title3":"The angiotensin IV/AT4 receptor"},{"title3":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas"},{"title3":"MAS and its related G protein-coupled receptors, Mrgprs"},{"title3":"Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure?"},{"title3":"Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation"},{"title3":"Pharmacology and signaling of MAS-related G protein-coupled receptors"},{"title3":"The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology"},{"title3":"Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor"},{"title3":"Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension"},{"title3":"Alamandine: a new member of the angiotensin family"},{"title3":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system"},{"title3":"Angiotensin (1-7) and Alamandine: Similarities and differences"},{"title3":"Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects"},{"title3":"A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology"},{"title3":"Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one-clip hypertensive rats"},{"title3":"Intratubular renin-angiotensin system in hypertension"},{"title3":"Unraveling the mystery of Goldblatt hypertension"},{"title3":"Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion"},{"title3":"Renal accumulation of circulating angiotensin II in angiotensin II- infused rats"},{"title3":"Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT1 receptor"},{"title3":"The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice"},{"title3":"Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion"},{"title3":"Two ACEs and a heart"},{"title3":"Kidney aminopeptidase A and hypertension, part II: effects of angiotensin II"},{"title3":"Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins"},{"title3":"Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice"},{"title3":"Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II"},{"title3":"Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats"},{"title3":"T and B cell development in BP-1/6C3/aminopeptidase A-deficient mice"},{"title3":"Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice"},{"title3":"Lack of angiotensin II conversion to angiotensin III increases water but not alcohol consumption in aminopeptidase A-deficient mice"},{"title3":"Ischemia-induced angiogenesis is impaired in aminopeptidase A deficient mice via down-regulation of HIF-1alpha"},{"title3":"Overexpression of aminopeptidase A abolishes the growth promoting effects of angiotensin II in cultured mouse mesangial cells"},{"title3":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure"},{"title3":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II"},{"title3":"Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease"},{"title3":"Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker"},{"title3":"Catabolism of angiotensin II"},{"title3":"Effects of angiotensins II and III on glomerulotubular balance in rats"},{"title3":"Aminopeptidase A activity and angiotensin III effects on [Ca2+]i along the rat nephron"},{"title3":"Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man"},{"title3":"Differential regulation of angiotensin peptide levels in plasma and kidney of the rat"},{"title3":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?"},{"title3":"Plasma and kidney angiotensin peptides: importance of the aminopeptidase A/angiotensin III axis"},{"title3":"Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice"},{"title3":"Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat"},{"title3":"In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney"},{"title3":"Nonclassical renin-angiotensin system and renal function"},{"title3":"Angiotensin III: A physiological relevant peptide of the renin angiotensin system"},{"title3":"Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake"},{"title3":"Regional haemodynamic effects of angiotensin II (3-8) in conscious rats"},{"title3":"Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat"},{"title3":"Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats"},{"title3":"Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor"},{"title3":"AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR"},{"title3":"AT2 receptor agonists: hypertension and beyond"},{"title3":"AT2 receptors: potential therapeutic targets for yypertension"},{"title3":"The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats"},{"title3":"Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications"},{"title3":"Angiotensin type 2 receptors: potential importance in the regulation of blood pressure"},{"title3":"Localization and properties of angiotensin II receptors in rat kidney"},{"title3":"The distribution of angiotensin II receptors"},{"title3":"Presence of angiotensin II AT2 receptor binding sites in the adventitia of human kidney vasculature"},{"title3":"Localization and properties of angiotensin converting enzyme and angiotensin II receptors in the heart"},{"title3":"Localization of angiotensin AT1 and AT2 receptors"},{"title3":"Molecular cloning and expression of the gene encoding human angiotensin II type 2 receptor"},{"title3":"AT2 receptor stimulation enhances antihypertensive effect of AT1 receptor antagonist in hypertensive rats"},{"title3":"Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system"},{"title3":"Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography"},{"title3":"In vivo occupancy of angiotensin II subtype 1 receptors in rat renal medullary interstitial cells"},{"title3":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice"},{"title3":"Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation"},{"title3":"Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation"},{"title3":"Genetic control of blood pressure and the angiotensinogen locus"},{"title3":"Male-female differences in fertility and blood pressure in ACE- deficient mice"},{"title3":"Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes"},{"title3":"Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II"},{"title3":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)"},{"title3":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis"},{"title3":"A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly"},{"title3":"Angiotensin II type 2 receptor mediates programmed cell death"},{"title3":"Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload"},{"title3":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension"},{"title3":"Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis"},{"title3":"Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla"},{"title3":"Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma"},{"title3":"Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats"},{"title3":"Angiotensin II type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zucker rats"},{"title3":"Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats"},{"title3":"Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells"},{"title3":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist"},{"title3":"Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential"},{"title3":"Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB"},{"title3":"Angiotensin AT2 receptor stimulation inhibits early renal inflammation in renovascular hypertension"},{"title3":"A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetes"},{"title3":"Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo"},{"title3":"Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia"},{"title3":"Angiotensin II type 2-receptor agonist C21 reduces proteinuria and oxidative stress in kidney of high-salt-fed obese Zucker rats"},{"title3":"Impact of the AT2 receptor agonist C21 on blood pressure and beyond"},{"title3":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats"},{"title3":"Angiotensin II type 2 receptor-mediated and nitric oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"The discovery of the ACE2 gene"},{"title3":"Angiotensin-converting enzyme II in the heart and the kidney"},{"title3":"Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes"},{"title3":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy"},{"title3":"Renal ACE2 expression in human kidney disease"},{"title3":"Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes"},{"title3":"Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease"},{"title3":"Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls"},{"title3":"Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice"},{"title3":"Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II"},{"title3":"The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function"},{"title3":"Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation"},{"title3":"Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension"},{"title3":"Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension"},{"title3":"Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice"},{"title3":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects"},{"title3":"Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents"},{"title3":"Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology"},{"title3":"Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation"},{"title3":"Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke"},{"title3":"Diminazene aceturate improves autonomic modulation in pulmonary hypertension"},{"title3":"Pharmacology of diminazene: a review"},{"title3":"Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models"},{"title3":"Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains"},{"title3":"The mas oncogene encodes an angiotensin receptor"},{"title3":"The mas oncogene enhances angiotensin-induced [Ca2+]i responses in cells with pre-existing angiotensin II receptors"},{"title3":"Cloning and functional characterization of a novel mas-related gene, modulating intracellular angiotensin II actions"},{"title3":"Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene"},{"title3":"Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+-ATPase activity through AT2 receptor"},{"title3":"Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats"},{"title3":"G-protein-coupled receptor MrgD is a receptor for angiotensin-(1-7) involving adenylyl cyclase, cAMP, and phosphokinase A"},{"title3":"Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain"},{"title3":"Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide"},{"title3":"Antenatal betamethasone attenuates the angiotensin-(1-7)/Mas receptor/nitric oxide axis in isolated proximal tubule cells"},{"title3":"Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene"},{"title3":"The genetic deletion of Mas abolishes salt induced hypertension in mice"},{"title3":"The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of mas-knockout mice"},{"title3":"Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice"},{"title3":"Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes"},{"title3":"Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes"},{"title3":"Angiotensin-(1-7): a new hormone of the angiotensin system"},{"title3":"Structural-activity relationship in angiotensin II analogs. Angiotensin"},{"title3":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system"},{"title3":"Angiotensin II and the heart : on the intracrine renin-angiotensin system"},{"title3":"Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction"},{"title3":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney"},{"title3":"Is angiotensin II a direct mediator of left ventricular hypertrophy?"},{"title3":"Paracrine regulation of the renal microcirculation"},{"title3":"Proximal nephron"},{"title3":"Stimulation of angiotensin type 1A receptors on catecholaminergic cells contributes to angiotensin-dependent hypertension"},{"title3":"Angiotensin-II, the brain, and hypertension: an update"},{"title3":"Angiotensin II-regulated transcription regulatory genes in adrenal steroidogenesis"},{"title3":"The regulation of aldosterone synthase expression"},{"title3":"Counterregulatory actions of angiotensin-(1-7)"},{"title3":"Nephrectomy, converting enzyme inhibition, and angiotensin peptides"},{"title3":"Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats"},{"title3":"ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR"},{"title3":"Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition"},{"title3":"Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats"},{"title3":"Expression of an angiotensin-(1-7)-producing fusion protein in rats induced marked changes in regional vascular resistance"},{"title3":"Renal function in transgenic rats expressing an angiotensin-(1-7)-producing fusion protein"},{"title3":"Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function"},{"title3":"Dose-dependent, therapeutic potential of angiotensin-(1-7) for the treatment of pulmonary arterial hypertension"},{"title3":"Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection"},{"title3":"AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium"},{"title3":"Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney"},{"title3":"Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats"},{"title3":"The nonpeptide angiotensin-(1-7) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction"},{"title3":"Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction"},{"title3":"AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice"},{"title3":"Antiatherosclerotic effect of Ang-(1-7) non-peptide mimetic (AVE 0991) is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis"},{"title3":"Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis"},{"title3":"AVE 0991 attenuates cardiac hypertrophy through reducing oxidative stress"},{"title3":"Dipeptidyl peptidase III is a zinc metallo-exopeptidase"},{"title3":"Purification and characterization of dipeptidyl aminopeptidase III from human placenta"},{"title3":"Dipeptidyl peptidase III from rat liver cytosol: purification, molecular cloning and immunohistochemical localization"},{"title3":"On Endogenous Angiotensin II Antagonism in Hypertension: The role of dipeptidyl peptidase III"},{"title3":"Identification of dipeptidyl peptidase 3 as the angiotensin-(1-7) degrading peptidase in human HK-2 renal epithelial cells"},{"title3":"The never-ending story of angiotensin peptides: beyond angiotensin I and II"},{"title3":"Mass-spectrometric identification of a novel angiotensin peptide in human plasma"},{"title3":"Differences in cardiovascular responses to alamandine in two-Kidney, one clip hypertensive and normotensive rats"},{"title3":"Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison"},{"title3":"Clinical relevance of local renin angiotensin systems"}]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","References":[{"title3":"Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019:COVID-NET, 14 States, March 1-30, 2020"},{"title3":"Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 infection"},{"title3":"Drugs and the renin-angiotensin system in covid-19"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study"},{"title3":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy"},{"title3":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19"},{"title3":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study"},{"title3":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality"},{"title3":"Coronavirus disease 2019 and hypertension: the role of angiotensin-converting enzyme 2 and the renin-angiotensin system"},{"title3":"Good ACE, bad ACE do battle in lung injury, SARS"},{"title3":"Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: implications for COVID-19"},{"title3":"Clinical and proteomic correlates of plasma ACE2 (angiotensin-converting enzyme 2) in human heart failure"},{"title3":"The expanding role of real-world evidence trials in health care decision making"},{"title3":"Real world evidence (RWE):are we (RWE) ready?"}]},{"title2":"HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19","References":[{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"COVID-19 and the cardiovascular system"}]},{"title2":"Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers","References":[]},{"title2":"Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance","References":[]},{"title2":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?","References":[]},{"title2":"Sex differences in immune responses.","References":[{"title3":"Sex Differences in the Adult Human Brain: Evidence from 5216 UK Biobank Participants"},{"title3":"X-factors in human disease: impact of gene content and dosage regulation"},{"title3":"Sex and gender: modifiers of health, disease, and medicine"},{"title3":"High expression of the mammalian X chromosome in brain"},{"title3":"Population-wide analysis of differences in disease progression patterns in men and women"},{"title3":"Sex Differences in Neurodegeneration: The Role of the Immune System in Humans"},{"title3":"Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging"},{"title3":"Gender differences in predictors of mortality in nursing home residents with AD"},{"title3":"Impact of Gender Differences on the Outcome of Alzheimer's Disease"},{"title3":"Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study"},{"title3":"Cognitive Performance in Subjects With Multiple Sclerosis Is Robustly Influenced by Gender in Canonical-Correlation Analysis"},{"title3":"Subcortical atrophy and cognition: sex effects in multiple sclerosis"},{"title3":"Sex-related factors in multiple sclerosis susceptibility and progression"},{"title3":"Sex specific cognitive differences in Parkinson disease"},{"title3":"Gender differences in Parkinson's disease"},{"title3":"Incidence of dementia in the oldest-old and its relationship with age: The Monzino 80-plus population-based study"},{"title3":"Effects of gender in amyotrophic lateral sclerosis"},{"title3":"Sex Biased Gene Expression Profiling of Human Brains at Major Developmental Stages"},{"title3":"Inflammation in neurodegenerative disease-a double-edged sword"},{"title3":"The impact of systemic infection on the progression of neurodegenerative disease"},{"title3":"Microglia in neurodegenerative disease"},{"title3":"Sex differences and similarities in the neuroimmune response to central administration of poly I:C"},{"title3":"The Lancet Commission on Dementia Prevention, Intervention, and Care: a call for action"},{"title3":"Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease"},{"title3":"Where are all the female participants in Sports and Exercise Medicine research? European Journal of Sport Science"},{"title3":"Biological Sex: A Potential Moderator of Physical Activity Efficacy on Brain Health"},{"title3":"Exercise and the Aging Brain: Considerations for Sex Differences"},{"title3":"The Role of Sex in Memory Function: Considerations and Recommendations in the Context of Exercise"},{"title3":"Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence"},{"title3":"Total daily physical activity and the risk of AD and cognitive decline in older adults"},{"title3":"The effects of cardiovascular exercise on human memory: a review with meta-analysis"},{"title3":"Dose-response relationship between exercise and cognitive function in older adults with and without cognitive impairment: A systematic review and meta-analysis"},{"title3":"Effects of chronic exercise interventions on executive function among children and adolescents: a systematic review with meta-analysis"},{"title3":"Exercise interventions for cognitive function in adults older than a systematic review with meta-analysis"},{"title3":"Aerobic exercise, cardiorespiratory fitness, and the human hippocampus"},{"title3":"The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials"},{"title3":"Estimating the lifetime risk of dementia in the Canadian elderly population using cross-sectional cohort survival data"},{"title3":"Systematic review and meta-analysis investigating moderators of long-term effects of exercise on cognition in healthy individuals"},{"title3":"Effects of aerobic exercise on mild cognitive impairment: a controlled trial"},{"title3":"Physical activity and risk of cognitive decline: a meta-analysis of prospective studies"},{"title3":"Sex differences in exercise efficacy to improve cognition: A systematic review and meta-analysis of randomized controlled trials in older humans"},{"title3":"Sex differences in aerobic exercise efficacy to improve cognition: A systematic review and meta-analysis of studies in older rodents"},{"title3":"Low-intensity daily walking activity is associated with hippocampal volume in older adults"},{"title3":"Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Abeta Pathology in Non-demented Individuals"},{"title3":"Sex-Specific Relationship Between Long-Term Maintenance of Physical Activity and Cognition in the Health ABC Study: Potential Role of Hippocampal and Dorsolateral Prefrontal Cortex Volume"},{"title3":"Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise"},{"title3":"Demographic and psychosocial correlates of physical activity in late life"},{"title3":"Gender differences in physical activity and walking among older adults"},{"title3":"The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease"},{"title3":"Muscle as an endocrine organ: focus on muscle-derived interleukin-6"},{"title3":"Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise"},{"title3":"Exercise and Toll-like receptors"},{"title3":"Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise?"},{"title3":"Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells"},{"title3":"Effect of exercise training intensity on murine T-regulatory cells and vaccination response"},{"title3":"Sex differences in immune responses"},{"title3":"The X chromosome and sex-specific effects in infectious disease susceptibility"},{"title3":"Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo "},{"title3":"The potential of endurance exercise-derived exosomes to treat metabolic diseases"},{"title3":"Exercise is the real polypill"},{"title3":"Integrative biology of exercise"},{"title3":"Exercise hormone irisin is a critical regulator of cognitive function"},{"title3":"Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function"},{"title3":"Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus"},{"title3":"VEGF is necessary for exercise-induced adult hippocampal neurogenesis"},{"title3":"Lactate Mediates the Effects of Exercise on Learning and Memory through SIRT1-Dependent Activation of Hippocampal Brain-Derived Neurotrophic Factor (BDNF)"},{"title3":"Maximal lactate steady state in running mice: effect of exercise training"},{"title3":"Exercise plasma boosts memory and dampens brain inflammation via clusterin"},{"title3":"Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain"},{"title3":"Exercise-Induced Activated Platelets Increase Adult Hippocampal Precursor Proliferation and Promote Neuronal Differentiation"},{"title3":"Exercise as a mean to control low-grade systemic inflammation"},{"title3":"Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations"},{"title3":"Role of myokines in exercise and metabolism"},{"title3":"Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content"},{"title3":"IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle"},{"title3":"Interleukin-6 in acute exercise and training: what is the biological relevance?"},{"title3":"Searching for the exercise factor: is IL-6 a candidate?"},{"title3":"The role of interleukin-6 signaling in nervous tissue"},{"title3":"Soluble receptors for cytokines and growth factors: generation and biological function"},{"title3":"Inflammatory blockade restores adult hippocampal neurogenesis"},{"title3":"Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells"},{"title3":"Astrocyte-derived interleukin-6 promotes specific neuronal differentiation of neural progenitor cells from adult hippocampus"},{"title3":"Influence of sex on cytokines, heat shock protein and oxidative stress markers in response to an acute total body resistance exercise protocol"},{"title3":"Sex-specific variation in signaling pathways and gene expression patterns in human leukocytes in response to endotoxin and exercise"},{"title3":"Sexual dimorphism of physical activity on cognitive aging: Role of immune functioning"},{"title3":"A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis"},{"title3":"The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion"},{"title3":"Is irisin the new player in exercise-induced adaptations or not? A update"},{"title3":"Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-athletes and are associated with bone density and strength estimates"},{"title3":"A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis"},{"title3":" , , , , , Thewonder exerkines:novel insights: a critical state-of-the-art review. Molecular and Cellular Biochemistry. 2021."},{"title3":"Muscles, exercise and obesity: skeletal muscle as a secretory organ"},{"title3":" , , , , , , .,Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway, Cell metabolism 2013;18."},{"title3":"Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model"},{"title3":"Sexual dimorphism in innate immunity"},{"title3":"Sex differences in the response to viral infections: TLR8 and TLR9 ligand stimulation induce higher IL10 production in males"},{"title3":"Alpha-2 macroglobulin is genetically associated with Alzheimer disease"},{"title3":"Origins, potency, and heterogeneity of skeletal muscle fibro-adipogenic progenitors: time for new definitions"},{"title3":"Single-cell transcriptional profiles in human skeletal muscle"},{"title3":"The impact of sex on gene expression across human tissues"},{"title3":"Skeletal muscle methylome and transcriptome integration reveals profound sex differences related to muscle function and substrate metabolism"},{"title3":"Toll-like receptor function and signaling"},{"title3":"Toll-like receptors-taking an evolutionary approach"},{"title3":"Toll-like receptors and innate immunity"},{"title3":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors"},{"title3":"Toll pathway-dependent blockade of CD4+CD25+T cell-mediated suppression by dendritic cells"},{"title3":"Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4"},{"title3":"The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men"},{"title3":"Influence of exercise training and age on CD14+cell-surface expression of toll-like receptor 2 and 4"},{"title3":"The physiological regulation of toll-like receptor expression and function in humans"},{"title3":"TLR7 escapes X chromosome inactivation in immune cells"},{"title3":"Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation"},{"title3":"TLR7 ligands induce higher IFN-alpha production in females"},{"title3":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1"},{"title3":"Effects of age, gender, and immunosuppressive agents on in vivo toll-like receptor pathway responses"},{"title3":"Biological sex affects vaccine efficacy and protection against influenza in mice"},{"title3":"Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: A possible mechanism for gender-based differences in endotoxic shock susceptibility"},{"title3":"Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice"},{"title3":"Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals"},{"title3":"TLR activation induces TNF-alpha production from adult neural stem/progenitor cells"},{"title3":"Preferential expression and function of Toll-like receptor 3 in human astrocytes"},{"title3":"Toll-like receptors in central nervous system glial inflammation and homeostasis"},{"title3":"The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA"},{"title3":"Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease"},{"title3":"Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis"},{"title3":"Role of toll-like receptor signalling in Abeta uptake and clearance"},{"title3":"Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits"},{"title3":"Non-cell-autonomous Neurotoxicity of alpha-synuclein Through Microglial Toll-like Receptor 2"},{"title3":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease"},{"title3":"Pathological alpha-synuclein exacerbates the progression of Parkinson's disease through microglial activation"},{"title3":"Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-kappaB signaling pathway"},{"title3":"Neuroprotective Effects of Endurance Exercise Against High-Fat Diet-Induced Hippocampal Neuroinflammation"},{"title3":"Effects of Toll-like receptor 4 inhibition on spatial memory and cell proliferation in male and female adult and aged mice"},{"title3":"Toll-like receptors modulate adult hippocampal neurogenesis"},{"title3":"Toll-like receptor 4 differentially regulates adult hippocampal neurogenesis in an age- and sex-dependent manner"},{"title3":"Evidence for a developmental role for TLR4 in learning and memory"},{"title3":"Young and aged TLR4 deficient mice show sex-dependent enhancements in spatial memory and alterations in interleukin-1 related genes"},{"title3":"The novel estrogenic receptor GPR30 alleviates ischemic injury by inhibiting TLR4-mediated microglial inflammation"},{"title3":"Sexually Dimorphic Role of Toll-like Receptor 4 (TLR4) in High Molecular Weight Hyaluronan (HMWH)-induced Anti-hyperalgesia"},{"title3":"Sex as a Biological Variable: A 5-Year Progress Report and Call to Action"},{"title3":"Transcriptomic profiling of skeletal muscle adaptations to exercise and inactivity"}]},{"title2":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection.","References":[{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Severe acute respiratory syndrome"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"The Pathology and Pathogenesis of Experimental Severe Acute Respiratory Syndrome and Influenza in Animal Models"},{"title3":"The Immunobiology of SARS*"},{"title3":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs"},{"title3":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice"},{"title3":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice"},{"title3":"Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?"},{"title3":"SARS in Singapore--predictors of disease severity"},{"title3":"The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health"},{"title3":"Sex differences in immune responses"},{"title3":"Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity"},{"title3":"Sex-associated hormones and immunity to protozoan parasites"},{"title3":"Role of sex steroid hormones in bacterial-host interactions"},{"title3":"Sex hormones and the immune response in humans"},{"title3":"Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats"},{"title3":"Elevated 17beta-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses"},{"title3":"17beta-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs"},{"title3":"CD200 receptor controls sex-specific TLR7 responses to viral infection"},{"title3":"Sex chromosome complement contributes to sex differences in coxsackievirus B3 but not influenza A virus pathogenesis"},{"title3":"The complex role of estrogens in inflammation"},{"title3":"The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men"},{"title3":"Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors"},{"title3":"Type I interferon is a therapeutic target for virus-induced lethal vascular damage"},{"title3":"Tamoxifen administration to mice"},{"title3":"Age-dependent dysregulation of innate immunity"},{"title3":"Implications of X-linked gene regulation for sex differences in disease pathogenesis (comment on DOI 10.1002/bies.201100047)"},{"title3":"The effects of hormones on sex differences in infection: from genes to behavior"},{"title3":"Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox"},{"title3":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1"},{"title3":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling"},{"title3":"Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages"},{"title3":"Estrogen inhibits lipopolysaccharide-induced tumor necrosis factor-alpha release from murine macrophages"},{"title3":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice"},{"title3":"Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice"},{"title3":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8"}]},{"title2":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal.","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China [in Chinese]"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19 [e-pub ahead of print]. N Engl J Med doi: 10.1056/NEJMoa2001282, Accessed March 15, 2020."},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"},{"title3":"First cases of COVID-19 in heart transplantation From China"},{"title3":"COVID-19: yet another coronavirus challenge in transplantation"},{"title3":"Epidemiological and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: a descriptive survey report"},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus"},{"title3":"Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China [e-pub ahead of print]. Clin Infect Dis doi: 10.1093/cid/ciaa248, Accessed March 15, 2020."},{"title3":"Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [e-pub ahead of print]. JAMA Intern Med doi: 10.1001/jamainternmed.2020.0994, Accessed March 15, 2020."},{"title3":"Mehta P, McAuley DF, Brown M,et al. COVID-19: consider cytokine storm syndromes and immunosuppression [e-pub ahead of print]. Lancet doi: 10.1016/S0140-6736(20)30628-0, Accessed March 15, 2020."}]},{"title2":"Angiotensin converting enzyme 2: a double-edged sword.","References":[{"title3":"Moccia F, Gerbino A, Lionetti V, Miragoli M, Munaron L, Pagliaro P et al (2020) COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches. GeroScience.:1-29"},{"title3":"Clinical implications of SARS-Cov2 interaction with renin angiotensin system"},{"title3":"Rahimi F, Abadi ATB (2020) Challenges of managing the asymptomatic carriers of SARS-CoV-2. Travel Med Infect Dis 101677. 10.1016/j.tmaid.2020.101677"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"SARS-CoV-2 productively infects human gut enterocytes"},{"title3":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes"},{"title3":"ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection"},{"title3":"Guo J, Wei X, Li Q, Li L, Yang Z, Shi Y, Qin Y, Zhang X, Wang X, Zhi X, Meng D (2020) Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury. J Cell Physiol. 10.1002/jcp.29802"},{"title3":"The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients"},{"title3":"Gattinoni L, Chiumello D, Rossi S (2020) COVID-19 pneumonia: ARDS or not? Crit Care 24:154. 10.1186/s13054-020-02880-z"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Russo V, Rago A, Carbone A, Bottino R, Ammendola E, Della Cioppa N, Galante D, Golino P, Nigro G (2020) Atrial fibrillation in COVID-19: from epidemiological association to pharmacological implications. J Cardiovasc Pharmacol 76:138-145. 10.1097/FJC.0000000000000854"},{"title3":"Iba T, Levy JH, Levi M, Connors JM, Thachil J Coagulopathy of coronavirus disease 2019. Crit Care Med:2020"},{"title3":"Yang C, Jin Z (2020) An acute respiratory infection runs into the most common noncommunicable epidemic:COVID-19 and cardiovascular diseases. JAMA Cardiol 5:743. 10.1001/jamacardio.2020.0934"},{"title3":"Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction"},{"title3":"Inflammatory differences in plaque erosion and rupture in patients with ST-segment elevation myocardial infarction"},{"title3":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Mitochondrial angiotensin receptors and cardioprotective pathways"},{"title3":"Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system"},{"title3":"Rethinking the renin-angiotensin system and its role in cardiovascular regulation"},{"title3":"Angiotensin converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis and diastolic dysfunction"},{"title3":"The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure"},{"title3":"Angiotensin II and nitric oxide interaction"},{"title3":"Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease"},{"title3":"Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation"},{"title3":"Gene silencing of endothelial von Willebrand factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells"},{"title3":"Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors"},{"title3":"Bradykinin-mediated angioedema"},{"title3":"Pattern of hospitalizations for angioedema in New York between 1990 and 2003"},{"title3":"Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N (2020) Effect of renin-angiotensin system inhibition on cardiac structure and function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials. Heart Fail Rev:1-8"},{"title3":"Gene therapy with angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction"},{"title3":"Role of ACE2 in diastolic and systolic heart failure"},{"title3":"Ferrario CM, Trask AJ, Jessup JA (2005) Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Phys Heart Circ Phys 289(6):H2281-H2H90. 10.1152/ajpheart.00618.2005"},{"title3":"ACE2, angiotensin-(1-7) and M as receptor axis in inflammation and fibrosis"},{"title3":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome"},{"title3":"Effects of inhibitors of the renin-angiotensin system on reducing blood pressure and expression of inflammatory factors in CHD patients: a network meta-analysis"},{"title3":"Plasma bradykinin in angio-oedema"},{"title3":"Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor-associated angioedema"},{"title3":"Unraveling the pivotal role of bradykinin in ACE inhibitor activity"},{"title3":"Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE"},{"title3":"Effects of antihypertensive drugs on endothelial dysfunction"},{"title3":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction"},{"title3":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease"},{"title3":"Hypotension in transgenic mice overexpressing human bradykinin B2 receptor"},{"title3":"Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme"},{"title3":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats"},{"title3":"Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan"},{"title3":"ACE inhibitor-induced angioedema: a review"},{"title3":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients"},{"title3":"Circulating plasma concentrations of ACE2 in men and women with heart failure and effects of renin-angiotensin-aldosterone-inhibitors"},{"title3":"The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction"},{"title3":"Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection"},{"title3":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway"},{"title3":"Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis"},{"title3":"Angiotensin II formation and endothelin clearance in ARDS patients in supine and prone positions"},{"title3":"Hemnes AR, Rathinasabapathy A, Austin EA, Brittain EL, Carrier EJ, Chen X et al (2018) A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur Respir J 51(6)"},{"title3":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics"},{"title3":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275(43):33238-33243"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Angiotensin-converting enzyme: zinc-and inhibitor-binding stoichiometries of the somatic and testis isozymes"},{"title3":"Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects"},{"title3":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Structural basis of receptor recognition by SARS-CoV-2"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 436(7047):112-116. 10.1038/nature03712"},{"title3":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors"},{"title3":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19 European Society of Hypertension COVID-19 Task Force Review of Evidence"},{"title3":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. In: Maier H., Bickerton E., Britton P. (eds) Coronaviruses. Methods in Molecular Biology, vol 1282. Humana Press, New York, NY. 10.1007/978-1-4939-2438-7_1"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension"},{"title3":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers"},{"title3":"Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis"},{"title3":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells"},{"title3":"Joint HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19"},{"title3":"Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P et al (2020) SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J 41:1801-3. 10.1093/eurheartj/ehaa235."},{"title3":"Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure"},{"title3":"Lionetti V, Barile L (2019) Perioperative cardioprotection: back to bedside. Minerva Anestesiol 86:445-54. 10.23736/S0375-9393.19.13848-5"}]},{"title2":"COVID-19 illness and heart failure: a missing link?","References":[{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Preprints"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"WHO Now Doesn't Recommend Avoiding Ibuprofen for COVID-19 Symptoms"},{"title3":"Seasonal influenza infections and cardiovascular disease mortality"},{"title3":"Heart failure induced by non-cardiac drugs"},{"title3":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy"},{"title3":"Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology"},{"title3":"Chimeric antigen receptor T-cell therapy for cancer and heart: JACC Council Perspectives"},{"title3":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-4."},{"title3":"Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab 2020;ChinaXiV:202003.00026v1."},{"title3":"HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19"}]}]},{"title1":"Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19","References":[{"title2":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.","References":[{"title3":"Influenza"},{"title3":"Norovirus classification and proposed strain nomenclature"},{"title3":"Wu, A. et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe10.1016/j.chom.2020.02.001 (2020)."},{"title3":"50 years of the International Committee on Taxonomy of Viruses: progress and prospects"},{"title3":"Gorbalenya, A. E., Lauber, C. &amp; Siddell, S. Taxonomy of Viruses, in Reference Module in Biomedical Sciences (Elsevier, 2019) 10.1016/B978-0-12-801238-3.99237-7."},{"title3":"The concept of virus species"},{"title3":"ICTV Code. The International Code of Virus Classification and Nomenclaturehttps://talk.ictvonline.org/information/w/ictv-information/383/ictv-code (2018)."},{"title3":"The molecular biology of coronaviruses"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"Middle East respiratory syndrome"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Snijder, E. J. et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol.331, 991-1004 (2003)."},{"title3":"van Boheemen, S. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio3, e00473-12 (2012)."},{"title3":"Additional changes to taxonomy ratified in a special vote by the International Committee on Taxonomy of Viruses (October 2018)"},{"title3":"Ziebuhr, J. et al. Proposal 2017.013S. A.v1. Reorganization of the family Coronaviridae into two families, Coronaviridae (including the current subfamily Coronavirinae and the new subfamily Letovirinae) and the new family Tobaniviridae (accommodating the current subfamily Torovirinae and three other subfamilies), revision of the genus rank structure and introduction of a new subgenus rank. (ICTV, 2017); https://ictv.global/proposal/2017.Nidovirales/."},{"title3":"Ziebuhr, J. et al. Proposal 2019.021S.Ac.v1. Create ten new species and a new genus in the subfamily Orthocoronavirinae of the family Coronaviridae and five new species and a new genus in the subfamily Serpentovirinae of the family Tobaniviridae. (ICTV, 2019); https://ictv.global/proposal/2019.Nidovirales/."},{"title3":"de Groot, R. J. et al. in Virus Taxonomy, Ninth Report of the International Committee on Taxonomy of Viruses (eds King, A. M. Q. et al.) 806-828 (Elsevier Academic Press, 2012)."},{"title3":"Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses"},{"title3":"The species problem in virology"},{"title3":"Partitioning the genetic diversity of a virus family: approach and evaluation through a case study of picornaviruses"},{"title3":"Mesoniviridae: a new family in the order Nidovirales formed by a single species of mosquito-borne viruses"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Zhou, P. et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Nature10.1038/s41586-020-2012-7 (2020)."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Gorbalenya, A. E. et al. The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks. Nat. Microbiol. (in the press)."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Kui, L. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. 10.1097/CM9.0000000000000744 (2020)."},{"title3":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 10.1056/nejmoa2001316 (2020)."},{"title3":"Liu, Y., Gayle, A. A., Wilder-Smith, A. &amp; Rocklov, J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 10.1093/jtm/taaa021 (2020)."},{"title3":"Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions"},{"title3":"Novel Coronavirus (2019-nCoV) Situation Report - 22 (World Health Organization, 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200211-sitrep-22-ncov.pdf"},{"title3":"Coronavirus disease (COVID-19) outbreak (World Health Organization, 2020); https://www.who.int/emergencies/diseases/novel-coronavirus-2019"},{"title3":"World Health Organization best practices for the naming of new human infectious diseases (World Health Organization, 2015); https://apps.who.int/iris/handle/10665/163636"},{"title3":"A nomenclature for avian coronavirus isolates and the question of species status"},{"title3":"Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae"},{"title3":"Molecular evolution of human coronavirus genomes"},{"title3":"PCR assays for detection of human astroviruses: In silico evaluation and design, and in vitro application to samples collected from patients in the Netherlands"},{"title3":"Binomial nomenclature for virus species: a consultation"},{"title3":"Practical application of bioinformatics by the multidisciplinary VIZIER consortium"},{"title3":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies"},{"title3":"Filterable viruses: a critical review"},{"title3":"The global virome project"},{"title3":"Expanding the RNA virosphere by unbiased metagenomics"},{"title3":"ICD-11 (World Health Organization, 2018)."},{"title3":"Hosts and sources of endemic human coronaviruses"},{"title3":"A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae"},{"title3":"A planarian nidovirus expands the limits of RNA genome size"},{"title3":"Recombination in large RNA viruses: Coronaviruses"},{"title3":"Molecular epidemiology, evolution and phylogeny of SARS coronavirus"},{"title3":"Surveillance of bat coronaviruses in Kenya identifies relatives of human coronaviruses NL63 and 229E and their recombination history"},{"title3":"Complete genome sequence of a severe acute respiratory syndrome-related coronavirus from Kenyan bats"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Viral evolution and the emergence of SARS coronavirus"},{"title3":"Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China.","References":[]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Blood pressure and the new ACC/AHA hypertension guidelines.","References":[]},{"title2":"US hypertension management guidelines: a review of the recent past and recommendations for the future.","References":[{"title3":"Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view"},{"title3":"Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012"},{"title3":"Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009"},{"title3":"Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association"},{"title3":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies"},{"title3":"Midlife hypertension and 20-year cognitive change: the Atherosclerosis Risk in Communities Neurocognitive Study"},{"title3":"Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure"},{"title3":"Clinical Practice Guidelines We Can Trust"},{"title3":"Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study"},{"title3":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)"},{"title3":"The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension"},{"title3":"2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)"},{"title3":"Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statement"},{"title3":"Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension"},{"title3":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)"},{"title3":"The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients"},{"title3":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)"},{"title3":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control"},{"title3":"Major hypertension trial stopped early for positive benefit with lower blood pressure control target"},{"title3":"Treatment of hypertension in patients 80 years of age or older"},{"title3":"(8) Cardiovascular disease and risk management"},{"title3":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline"},{"title3":"NICE guideline on hypertension"},{"title3":"A comparison of observational studies and randomized, controlled trials"},{"title3":"Comparison of evidence of treatment effects in randomized and nonrandomized studies"},{"title3":"Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population"},{"title3":"Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis"},{"title3":"Cost-effectiveness of hypertension therapy according to 2014 guidelines"},{"title3":"Proportion of US adults potentially affected by the 2014 hypertension guideline"},{"title3":"Impact of the 2014 expert panel recommendations for management of high blood pressure on contemporary cardiovascular practice: insights from the NCDR PINNACLE registry"},{"title3":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data"},{"title3":"2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines"},{"title3":"Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease"},{"title3":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group"},{"title3":"Effects morbidity of treatment on in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg"},{"title3":"MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party"},{"title3":"Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group"},{"title3":"Is a systolic blood pressure target &lt;140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial"},{"title3":"Effects of intensive blood-pressure control in type 2 diabetes mellitus"},{"title3":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial"},{"title3":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial"},{"title3":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group"},{"title3":"Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention"},{"title3":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial"},{"title3":"2014 Eighth Joint National Committee Panel recommendation for blood pressure targets revisited: results from the INVEST study"},{"title3":"Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension"},{"title3":"Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group"},{"title3":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol"},{"title3":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)"},{"title3":"2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines"},{"title3":"Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force"}]},{"title2":"Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.","References":[]},{"title2":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.","References":[]},{"title2":"A new coronavirus associated with human respiratory disease in China.","References":[]},{"title2":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.","References":[{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"The Genome sequence of the SARS-associated coronavirus"},{"title3":"Severe Acute Respiratory Syndrome (SARS) Epidemiology Working Group. WHO consensus document on the epidemiology of severe acute respiratory syndrome (SARS). (http://www.who.int/csr/sars/en/WHOconsensus.pdf, 2003)."},{"title3":"Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology"},{"title3":"Updating the accounts: global mortality of the 1918-1920 &quot;Spanish&quot; influenza pandemic"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"World Health Organization. Confirmed human cases of avian influenza A (H5N1), 7 September 2004. (http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2004_09_07/en/print.html, 2004)."},{"title3":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice"},{"title3":"Imai, Y. et al. The SARS-coronavirus receptor angiotensin coverting enzyme 2 protects from severe acute lung failure. Nature (in the press)."},{"title3":"Chemokine receptor trafficking and viral replication"},{"title3":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN"},{"title3":"193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2"},{"title3":"Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Human coronaviruses-a brief review"},{"title3":"ACE1 polymorphism and progression of SARS"},{"title3":"Analysis on the SARS-CoV genome of PUMC01 isolate"},{"title3":"Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation"}]},{"title2":"New Coronavirus Pneumonia Prevention and Control Program.","References":[]},{"title2":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases Interim guidance.","References":[]},{"title2":"Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected.","References":[]},{"title2":"Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury.","References":[]},{"title2":"Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS).","References":[]},{"title2":"Comparison of imputation methods for missing laboratory data in medicine.","References":[{"title3":"Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines"},{"title3":"Machine learning algorithms outperform conventional regression models in identifying risk factors for hepatocellular carcinoma in patients with cirrhosis"},{"title3":"Multiple imputation of missing blood pressure covariates in survival analysis"},{"title3":"Missing value estimation methods for DNA microarrays"},{"title3":"MissForest:non-parametric missing value imputation for mixed-type data"},{"title3":"Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis"},{"title3":"A general coefficient of similarity and some of its properties"}]},{"title2":"Sensitivity analysis in observational research: introducing the E-Value.","References":[]},{"title2":"Web site and R Package for computing E-values.","References":[{"title3":"Sensitivity analysis in observational research: Introducing the E-value"},{"title3":"Sensitivity analysis without assumptions"},{"title3":"Sensitivity analysis for unmeasured confounding: E-values for observational studies"}]},{"title2":"Using the E-Value to assess the potential effect of unmeasured confounding in observational studies.","References":[]},{"title2":"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician.","References":[]},{"title2":"A statement from the International Society of Hypertension on COVID-19.","References":[]},{"title2":"Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis.","References":[{"title3":"Infectious diseases. MERS surges again, but pandemic jitters ease"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Treatment with interferon-[alpha] 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration"},{"title3":"Case report guidelines"},{"title3":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses"},{"title3":"Meta-analysis in clinical trials"},{"title3":"Measuring inconsistency in meta-analyses [journal article as teaching resource, deposited by John Flynn]"},{"title3":"Meta-analysis of genetic association studies"},{"title3":"Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches"},{"title3":"Post-dengue acute disseminated encephalomyelitis: a case report and meta-analysis"},{"title3":"MERS CoV infection in two renal transplant recipients: case report"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"A patient with severe respiratory failure caused by novel human coronavirus"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Middle Eastern respiratory syndrome corona virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Middle East respiratory syndrome coronavirus in children"},{"title3":"Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia"},{"title3":"A family cluster of Middle East respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Infection prevention/control and management guidelines for patients with Middle East respiratory syndrome coronavirus (MERS CoV) infection"},{"title3":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome"}]},{"title2":"Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis.","References":[{"title3":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) into the United States"},{"title3":"The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012"},{"title3":"First cases of middle east respiratory syndrome coronavirus (MERS-COV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Case fatality: rate, ratio, or risk?"},{"title3":"Middle East respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility"},{"title3":"Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea, May-June 2015"},{"title3":"Estimating the Severity and Subclinical Burden of Middle East Respiratory Syndrome Coronavirus Infection in the Kingdom of Saudi Arabia"},{"title3":"Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015"},{"title3":"Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015"},{"title3":"Systematic Reviews and Meta Analysis of Published Studies: An overview and Best Practices"},{"title3":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement"},{"title3":"A family cluster of Middle East Respiratory Syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Community Case Clusters of Middle East Respiratory Syndrome Coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: A Descriptive Genomic study"},{"title3":"Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection"},{"title3":"Acute Management and Long-Term Survival Among Subjects With Severe Middle East Respiratory Syndrome Coronavirus Pneumonia and ARDS"},{"title3":"Characteristics and Outcomes of Middle East Respiratory Syndrome Coronavirus Patients Admitted to an Intensive Care Unit in Jeddah, Saudi Arabia"},{"title3":"Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients"},{"title3":"Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description"},{"title3":"Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015"},{"title3":"Acute Middle East respiratory syndrome coronavirus: Temporal lung changes observed on the chest radiographs of 55 patients"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: An observational study"},{"title3":"Middle East respiratory syndrome coronavirus: A case-control study of hospitalized patients"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia"},{"title3":"CT correlation with outcomes in 15 patients with acute Middle East respiratory syndrome coronavirus"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: A retrospective study"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans"},{"title3":"Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015"},{"title3":"Mortality Risk Factors for Middle East Respiratory Syndrome Outbreak, South Korea, 2015"},{"title3":"The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012-2015"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus"},{"title3":"Risk of MERS importation and onward transmission: a systematic review and analysis of cases reported to WHO"},{"title3":"Predicting the international spread of Middle East respiratory syndrome (MERS)"},{"title3":"Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis"}]},{"title2":"Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity.","References":[]},{"title2":"Role of the immune system in hypertension.","References":[{"title3":"Risk stratification and medical therapy of pulmonary arterial hypertension"},{"title3":"Pulmonary arterial hypertension: Pathogenesis and clinical manage-ment"},{"title3":"Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)"},{"title3":"New Echo-cardiographic Tehniques in Pulmonary Arterial Hypertension vs. Right Heart Catheterization:A Pilot Study"},{"title3":"The Right Ventricle Explains Sex Differences in Survival in Idiopathic Pulmonary Arterial Hypertension"},{"title3":"Sex differences in response to pulmonary arterial hypertension therapy: Is what's good for the goose, good for the gender?"},{"title3":"2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension"},{"title3":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension"},{"title3":"Whatever turns you on: Accessory-cell-dependent activation of NK cells by pathogens"},{"title3":"NK cell development, homeostasis and function: Parallels with CD8+ T cells"},{"title3":"Nowe Mechanizmy aktywacji komorek NK w przebiegu infekcji wirusowych"},{"title3":"Biologia komorek NK (Natural Killer)"},{"title3":"Natural killer cells as an initial defense against pathogens"},{"title3":"Natural killer cells: Integrating diversity with function"},{"title3":"All is fair in virus-host interactions: NK cells and cytomegalovirus"},{"title3":"Immune cells and autoantibodies in pulmonary arterial hypertension"},{"title3":"Impaired Natural Killer Cell Phenotype and Function in Idiopathic and Heritable Pulmonary Arterial Hypertension"},{"title3":"Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension"},{"title3":"Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension"},{"title3":"Inflammation, Growth Factors, and Pulmonary Vascular Remodeling"},{"title3":"HIV and autoimmunity"},{"title3":"Human herpesvirus 8 in classic Kaposi sarcoma"},{"title3":"Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular Remodeling"},{"title3":"Innate Immunity in the Therapeutic Actions of Endothelial Progenitor Cells in Pulmonary Hypertension"},{"title3":"Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency"},{"title3":"Heterogeneity of human effector CD4+ T cells"},{"title3":"CD4+CD25+ T Cells Regulate Virus-specific Primary and Memory CD8+ T Cell Responses"},{"title3":"Cornerstone of peripheral tolerance: Naturally occurring CD4+CD25+ regulatory T cells"},{"title3":"Tolerance, not immunity, crucially depends on IL-2"},{"title3":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation"},{"title3":"Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: Data from the Polish multicenter registry (BNP-PL)"},{"title3":"Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hyper-tension"},{"title3":"Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension"},{"title3":"Regulatory T Cells and Immune Tolerance"},{"title3":"FOXP3+ regulatory T cells in the human immune system"},{"title3":"Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension"},{"title3":"Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension"},{"title3":"Antinuclear antibodies in primary pulmonary hyper-tension"},{"title3":"Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension"},{"title3":"Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: A cross sectional study"},{"title3":"Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension"},{"title3":"The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension"},{"title3":"Differential release of mast cell mediators and the pathogenesis of inflammation"},{"title3":"The Master Switch: The Role of Mast Cells in Autoimmunity and Tolerance"},{"title3":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension"},{"title3":"Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension"},{"title3":"Interleukin-6 overexpression induces pulmonary hypertension"},{"title3":"Severe Pulmonary Arterial Hypertension Induced by SU5416 and Ovalbumin Immunization"},{"title3":"Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis"},{"title3":"B lymphocytes and systemic sclerosis"},{"title3":"Inflammation and autoimmunity in pulmonary hypertension: Is there a role for endothelial adhesion molecules?"},{"title3":"Early Macrophage Recruitment and Alternative Activation Are Critical for the Later Development of Hypoxia-Induced Pulmonary Hypertension"},{"title3":"Altered Macrophage Polarization Induces Experimental Pulmonary Hypertension and Is Observed in Patients with Pulmonary Arterial Hypertension"},{"title3":"Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model"},{"title3":"Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension"},{"title3":"Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension"},{"title3":"Reciprocal regulation of polarized cytokine production by effector B and T cells"},{"title3":"The IL-2 Receptor Complex: Its Structure, Function, and Target Genes"},{"title3":"Biological properties of interleukin 2 and its role in pathogenesis of selected diseases:A review"},{"title3":"The main function of IL-2 is to promote the development of T regulatory cells"},{"title3":"Overview of interleukin-2 function, production and clinical applications"},{"title3":"Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off"},{"title3":"An upregulation of CD8+CD25+Foxp3+ T cells with suppressive function through interleukin 2 pathway in pulmonary arterial hypertension"},{"title3":"Cardiopulmonary effects of recombinant interleukin-2 infusion in sheep"},{"title3":"Induction of endothelin-1 synthesis by IL-2 and its modulation of rat intestinal epithelial cell growth"},{"title3":"The two faces of IL-6 on Th1/Th2 differentiation"},{"title3":"SOCS3 negatively regulates IL-6 signaling in vivo"},{"title3":"IL-2 induces pulmonary edemaand vasoconstriction independent of circulating lymphocytes"},{"title3":"Interleukin-6: From an inflammatory marker to a target for inflammatory diseases"},{"title3":"Inflammation in pulmonary hypertension: What we know and what we could logically and safely target first"},{"title3":"Epicardial, paracardial and perivascular fat quantity, genes expression and serum cytokines in coronary artery disease and diabetes"},{"title3":"Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension"},{"title3":"Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension"},{"title3":"Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension"},{"title3":"Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage"},{"title3":"Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease"},{"title3":"The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman's disease"},{"title3":"Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension"},{"title3":"Short and long term anti-inflammatory effects of bosentan therapy in patients with pulmonary arterial hypertension: Relation to clinical and hemodynamic responses"},{"title3":"Inflammatory cytokines and cardiovascular disease"},{"title3":"Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats"},{"title3":"Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway"},{"title3":"IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo"},{"title3":"Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice"},{"title3":"Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy"},{"title3":"IL-4 in the Brain: A Cytokine to Remember"},{"title3":"Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2"},{"title3":"Hypoxia-Induced Mitogenic Factor (HIMF/FIZZ1/RELMalpha) Increases Lung Inflammation and Activates Pulmonary Microvascular Endothelial Cells via an IL-4-Dependent Mechanism"},{"title3":"Hypoxia-induced mitogenic factor (FIZZ1/RELMalpha) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension"},{"title3":"Viruses and interferon: A fight for supremacy"},{"title3":"Interferon-gamma and systemic autoimmunity"},{"title3":"Vascular Events Associated with Alpha Interferon Therapy"},{"title3":"Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: A case report"},{"title3":"Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C"},{"title3":"Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin"},{"title3":"Negative regulators of T-cell activation: Potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections"},{"title3":"Protein kinase C-eta controls CTLA-4-mediated regulatory T cell function"},{"title3":"Anti-PD-1/PD-L1 therapy of human cancer: Past, present, and future"},{"title3":"CTLA-4 (CD152) and its involvement in autoimmune disease"},{"title3":"Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: An in vitro model to monitor cellular immune function"},{"title3":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition"},{"title3":"Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy"},{"title3":"Overexpression of PD-1 on Peripheral Blood Lymphocytes in Patients with Idiopathic Pulmonary Arterial Hypertension and Its Association with High Viral Loads of Epstein-Barr Virus and Poor Clinical Parameters"},{"title3":"T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension"},{"title3":"The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans"},{"title3":"The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes"},{"title3":"Heterogeneity in the CD200R paired receptor family"},{"title3":"Identification of an Expressed Truncated Form of CD200, CD200tr, which is a Physiologic Antagonist of CD200-Induced Suppression"},{"title3":"Understanding the neurobiology of CD200 and the CD200 receptor: A therapeutic target for controlling inflammation in human brains?"},{"title3":"Regulation of Myeloid Cell Function through the CD200 Receptor"},{"title3":"Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells"},{"title3":"Expression of CD200 in alternative activation of microglia following an excitotoxic lesion in the mouse hippocampus"},{"title3":"Novel CD200 homologues iSEC1 and iSEC2 are gastrointestinal secretory cell-specific ligands of inhibitory receptor CD200R"},{"title3":"Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200"},{"title3":"Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes"},{"title3":"CD200R1 Supports HSV-1 Viral Replication and Licenses Pro-Inflammatory Signaling Functions of TLR2"},{"title3":"Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients"},{"title3":"Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions"},{"title3":"A critical function for CD200 in lung immune homeostasis and the severity of influenza infection"},{"title3":"Reduced expression of monocyte CD200R is associated with enhanced proinflammatory cytokine production in sarcoidosis"},{"title3":"Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells"},{"title3":"Mice Lacking CD200R1 Show Absence of Suppression of Lipopolysaccharide-Induced Tumor Necrosis Factor-alpha and Mixed Leukocyte Culture Responses by CD200"},{"title3":"Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation"},{"title3":"Soluble CD200 Correlates with Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course"},{"title3":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade"},{"title3":"Constitutive Retinal CD200 Expression Regulates Resident Microglia and Activation State of Inflammatory Cells during Experimental Autoimmune Uveoretinitis"},{"title3":"Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis rats"},{"title3":"Monoclonal Antibody-Mediated CD200 Receptor Signaling Suppresses Macrophage Activation and Tissue Damage in Experimental Autoimmune Uveoretinitis"},{"title3":"CD200 Ligand Receptor Interaction Modulates Microglial Activation In Vivo and In Vitro: A Role for IL-4"},{"title3":"Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex"},{"title3":"High CD200 Expression on T CD4+ and T CD8+ Lymphocytes as a Non-Invasive Marker of Idiopathic Pulmonary Hypertension-Preliminary Study"},{"title3":"Programmed Death 1 Pathway inhibition in Metastatic Renal Cell Cancer and Prostate Cancer"},{"title3":"Immune Therapy for Kidney Cancer: A Second Dawn?"},{"title3":"Molecular Pathways: Next-Generation Immunotherapy:Inhibiting Programmed Death-Ligand 1 and Programmed Death-1"},{"title3":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death"},{"title3":"Hallmarks of Cancer: The Next Generation"},{"title3":"Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation"},{"title3":"PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells"},{"title3":"Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity"},{"title3":"A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy"},{"title3":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations"},{"title3":"Tissue expression of PD-L1 mediates peripheral T cell tolerance"},{"title3":"PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells"},{"title3":"Restoring function in exhausted CD8 T cells during chronic viral infection"},{"title3":"Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice"},{"title3":"PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation"},{"title3":"PD-1 signaling in primary T cells"},{"title3":"Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1"},{"title3":"T cell differentiation in chronic infection and cancer: Functional adaptation or exhaustion?"},{"title3":"High antigen levels induce an exhausted phenotype in a chronic infection without impairing T cell expansion and survival"},{"title3":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection"},{"title3":"Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients"},{"title3":"A checkpoint on innate myeloid cells in pulmonary arterial hypertension"},{"title3":"Inflammation in Pulmonary Arterial Hypertension"},{"title3":"Ghofrani. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: Results of the randomized IMPRES study"},{"title3":"TNFalpha drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling"},{"title3":"Phenotypically silent bone morphogenetic protein receptor 2 mutations predispose rats to inflammation-induced pulmonary arterial hypertension by enhancing the risk for neointimal transformation"},{"title3":"Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension"},{"title3":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension"},{"title3":"Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension"},{"title3":"Investigational pharmacotherapy and immunotherapy of pulmonary arterial hypertension: An update"},{"title3":"Apelin/APJ system: An emerging therapeutic target for respiratory diseases"},{"title3":"The Rho kinase inhibitor azaindole-1 has long-acting vasodilator activity in the pulmonary vascular bed of the intact chest rat"},{"title3":"Protective effects of 18beta-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway"},{"title3":"The acute effects of 30 mg vs 60 mg of intravenous Fasudil on patients with congenital heart defects and severe pulmonary arterial hypertension"}]},{"title2":"NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.","References":[{"title3":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress"},{"title3":"Regulation of signal transduction by reactive oxygen species in the cardiovascular system"},{"title3":"Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes"},{"title3":"ROS-induced ROS release in vascular biology: redox-redox signaling"},{"title3":"The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases"},{"title3":"Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences"},{"title3":"NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease"},{"title3":"Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase"},{"title3":"Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors"},{"title3":"Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process"},{"title3":"Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin"},{"title3":"Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension"},{"title3":"Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice"},{"title3":"Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase"},{"title3":"Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load"},{"title3":"Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice"},{"title3":"A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression"},{"title3":"Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice"},{"title3":"Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension"},{"title3":"Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure"},{"title3":"Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability"},{"title3":"Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity"},{"title3":"Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease"},{"title3":"Tetrahydrobiopterin deficiency and nitric oxide synthase uncoupling contribute to atherosclerosis induced by disturbed flow"},{"title3":"The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes"},{"title3":"Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid"},{"title3":"Endothelium-specific sepiapterin reductase deficiency in DOCA-salt hypertension"},{"title3":"Recoupling of eNOS with folic acid prevents abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E null mice"},{"title3":"Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm"},{"title3":"Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS"},{"title3":"Nifedipine attenuation of abdominal aortic aneurysm in hypertensive and non-hypertensive mice: mechanisms and implications"},{"title3":"Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension"},{"title3":"NOX isoforms in the development of abdominal aortic aneurysm"},{"title3":"Bone morphogenic protein 4 mediates NOX1-dependent eNOS uncoupling, endothelial dysfunction, and COX2 induction in type 2 diabetes mellitus"},{"title3":"Novel treatment of hypertension by specifically targeting E2F for restoration of endothelial dihydrofolate reductase and eNOS function under oxidative stress"},{"title3":"Knockout of dihydrofolate reductase in mice induces hypertension and abdominal aortic aneurysm via mitochondrial dysfunction"},{"title3":"Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species"},{"title3":"Cross talk between mitochondria and NADPH oxidases"},{"title3":"Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function"},{"title3":"Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction"},{"title3":"Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels"},{"title3":"Oxidative stress and hypertensive diseases"},{"title3":"NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice"},{"title3":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis"},{"title3":"Differential roles of NADPH oxidases in vascular physiology and pathophysiology"},{"title3":"NADPH oxidases in vascular pathology"},{"title3":"Physiological and pathological functions of NADPH oxidases during myocardial ischemia-reperfusion"},{"title3":"NADPH oxidases as therapeutic targets in ischemic stroke"},{"title3":"Pathophysiology and treatments of oxidative injury in ischemic stroke: focus on the phagocytic nadph oxidase 2"},{"title3":"NADPH oxidases in heart failure: poachers or gamekeepers?"},{"title3":"Redox regulation of cardiac hypertrophy"},{"title3":"Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase"},{"title3":"Vascular NADPH oxidases as drug targets for novel antioxidant strategies"},{"title3":"Oxidative stress and hypertension: current concepts"},{"title3":"Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice"},{"title3":"p47phox is required for atherosclerotic lesion progression in ApoE-/- mice"},{"title3":"Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor 1alpha and upregulation of peroxisome proliferator-activated receptor-alpha"},{"title3":"NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart"},{"title3":"NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish"},{"title3":"Biochemical aspects of phagocytosis"},{"title3":"Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells"},{"title3":"Novel cytochrome b system in phagocytic vacuoles of human granulocytes"},{"title3":"Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease"},{"title3":"Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location"},{"title3":"The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex"},{"title3":"Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors"},{"title3":"Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease"},{"title3":"Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1"},{"title3":"Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2"},{"title3":"p40phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains"},{"title3":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells"},{"title3":"Cell transformation by the superoxide-generating oxidase Mox1"},{"title3":"A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1"},{"title3":"NADPH oxidase subunit, gp91phox homologue, preferentially expressed in human colon epithelial cells"},{"title3":"Identification of renox, an NAD(P)H oxidase in kidney"},{"title3":"Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family"},{"title3":"Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox"},{"title3":"A Ca2+-activated NADPH oxidase in testis, spleen, and lymph nodes"},{"title3":"Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5"},{"title3":"Two novel proteins activate superoxide generation by the NADPH oxidase NOX1"},{"title3":"Proteins homologous to p47phox and p67phox support superoxide-production by NAD(P)H oxidase 1 in colon epithelial cells"},{"title3":"Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases"},{"title3":"Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent"},{"title3":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology"},{"title3":"Nox1 in cardiovascular diseases: regulation and pathophysiology"},{"title3":"A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease"},{"title3":"The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators"},{"title3":"Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes"},{"title3":"Structure of the N-terminal regulatory domain of a plant NADPH oxidase and its functional implications"},{"title3":"Crystal structures and atomic model of NADPH oxidase"},{"title3":"Nox family NADPH oxidases: molecular mechanisms of activation"},{"title3":"Expression and localization of NOX2 and NOX4 in primary human endothelial cells"},{"title3":"Regulation of the superoxide-generating NADPH oxidase by a small GTP-binding protein and its stimulatory and inhibitory GDP/GTP exchange proteins"},{"title3":"Regulation of the human neutrophil NADPH oxidase by rho-related G-proteins"},{"title3":"Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways"},{"title3":"Phosphorylation of p47phox sites by PKC alpha, betaII, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation"},{"title3":"Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy"},{"title3":"Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress"},{"title3":"Molecular basis of phosphorylation-induced activation of the NADPH oxidase"},{"title3":"Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators"},{"title3":"Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement"},{"title3":"NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?"},{"title3":"Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells"},{"title3":"Mechanism of Ca2+ activation of the NADPH oxidase 5 (NOX5)"},{"title3":"The emerging role of NADPH oxidase NOX5 in vascular disease"},{"title3":"Cloning, characteristics, and functional analysis of rabbit NADPH oxidase 5"},{"title3":"NOX5 variants are functionally active in endothelial cells"},{"title3":"Enzymatic regulation and functional relevance of NOX5"},{"title3":"NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin"},{"title3":"Regulation of NADPH oxidase 5 by protein kinase C isoforms"},{"title3":"Calcium/calmodulin-dependent kinase II mediates the phosphorylation and activation of NADPH oxidase 5"},{"title3":"Molecular regulation of NADPH oxidase 5 via the MAPK pathway"},{"title3":"Redox signaling, Nox5 and vascular remodeling in hypertension"},{"title3":"Regulation of Nox and Duox enzymatic activity and expression"},{"title3":"Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system"},{"title3":"Differential vascular functions of Nox family NADPH oxidases"},{"title3":"NAD(P)H oxidases in rat basilar arterial endothelial cells"},{"title3":"A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall"},{"title3":"Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease"},{"title3":"The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle"},{"title3":"NOX1/NADPH oxidase is involved in endotoxin-induced cardiomyocyte apoptosis"},{"title3":"Leptin, endothelin, NADPH oxidase, and heart failure"},{"title3":"Increased myocardial NADPH oxidase activity in human heart failure"},{"title3":"Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction"},{"title3":"NOX5 expression is increased in intramyocardial blood vessels and cardiomyocytes after acute myocardial infarction in humans"},{"title3":"Regulation of ROS signal transduction by NADPH oxidase 4 localization"},{"title3":"Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local Ras activation"},{"title3":"Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells"},{"title3":"Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype"},{"title3":"Ultrastructural analysis and electron microscopic localization of Nox4 in healthy and atherosclerotic human aorta"},{"title3":"Vascular NOX (NADPH oxidase) compartmentalization, protein hyperoxidation, and endoplasmic reticulum stress response in hypertension"},{"title3":"Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase"},{"title3":"Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy"},{"title3":"Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production"},{"title3":"Identification of structural elements in Nox1 and Nox4 controlling localization and activity"},{"title3":"The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4"},{"title3":"Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: comparison of sensitivity and specificity"},{"title3":"Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension"},{"title3":"Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling"},{"title3":"Tetrahydrobiopterin biosynthesis, regeneration and functions"},{"title3":"Mechanisms underlying endothelial dysfunction in diabetes mellitus"},{"title3":"Uncoupling endothelial nitric oxide synthase is ameliorated by green tea in experimental diabetes by re-establishing tetrahydrobiopterin levels"},{"title3":"High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury"},{"title3":"Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure"},{"title3":"Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension"},{"title3":"Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center"},{"title3":"Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase"},{"title3":"Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase"},{"title3":"Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite"},{"title3":"Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite"},{"title3":"S-glutathionylation uncouples eNOS and regulates its cellular and vascular function"},{"title3":"Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan"},{"title3":"Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression"},{"title3":"Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy"},{"title3":"Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase"},{"title3":"Generation of superoxide by purified brain nitric oxide synthase"},{"title3":"Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury"},{"title3":"Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes"},{"title3":"Hydroperoxide metabolism in mammalian organs"},{"title3":"Modulation of potassium channel activity in the balance of ROS and ATP production by durum wheat mitochondria : an amazing defense tool against hyperosmotic stress"},{"title3":"Redox regulation of the mitochondrial KATP channel in cardioprotection"},{"title3":"Mitochondrial KATP channels: role in cardioprotection"},{"title3":"Mitochondrial potassium channels and reactive oxygen species"},{"title3":"P Triggering mitochondrial radical release: a new function for NADPH oxidases"},{"title3":"Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide"},{"title3":"The pathobiology of diabetic complications: a unifying mechanism"},{"title3":"Mitochondrial proton and electron leaks"},{"title3":"Mitochondrial dysfunction in atherosclerosis"},{"title3":"Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome C reductase from beef-heart mitochondria"},{"title3":"Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space"},{"title3":"Pathophysiological roles of NADPH oxidase/NOX family proteins in the vascular system. Review and perspective"},{"title3":"Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy"},{"title3":"Mitochondrial integrity and function in atherogenesis"},{"title3":"Mitochondrial reactive oxygen species and type 1 diabetes"},{"title3":"Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans"},{"title3":"Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium"},{"title3":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Gaq overexpression-induced heart failure"},{"title3":"Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications"},{"title3":"The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients"},{"title3":"MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice"},{"title3":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage"},{"title3":"Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy"},{"title3":"Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase"},{"title3":"Marked elevation in cortical urate and xanthine oxidoreductase activity in experimental bacterial meningitis"},{"title3":"Characterization of the differentiated antioxidant profile of human saliva"},{"title3":"Does superoxide underlie the pathogenesis of hypertension?"},{"title3":"Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats"},{"title3":"A mechanism of oxygen free radical production in the Dahl hypertensive rat"},{"title3":"Effect of azapropazone and allopurinol on myocardial infarct size in rats"},{"title3":"Effects of allopurinol on reperfusion arrhythmias in isolated ventricles"},{"title3":"Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy"},{"title3":"Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?"},{"title3":"The effect of the addition of allopurinol on blood pressure control in African Americans treated with a thiazide-like diuretic"},{"title3":"Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study"},{"title3":"Effect of xanthine oxidase inhibition on arterial stiffness in patients with chronic heart failure"},{"title3":"Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies"},{"title3":"Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in postischemic heart"},{"title3":"PGC-alphaa overexpression suppresses blood pressure elevation in DOCA-salt hypertensive mice"},{"title3":"Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms"},{"title3":"Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals"},{"title3":"NADPH oxidases: functions and pathologies in the vasculature"},{"title3":"Therapeutic targeting of mitochondrial superoxide in hypertension"},{"title3":"Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. formation of novel nitrogen-containing oxidized lipid derivatives"},{"title3":"Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease"},{"title3":"Metallothionein abrog ates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis"},{"title3":"Coenzyme Q10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus"},{"title3":"Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'"},{"title3":"Xanthine oxidase contributes to mitochondrial ROS generation in an experimental model of cocaine-induced diastolic dysfunction"},{"title3":"Novel insights into interactions between mitochondria and xanthine oxidase in acute cardiac volume overload"},{"title3":"Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone"},{"title3":"p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats"},{"title3":"NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat"},{"title3":"Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats"},{"title3":"Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension"},{"title3":"Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats"},{"title3":"Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats"},{"title3":"Targeting reactive oxygen species in hypertension"},{"title3":"Molecular mechanisms of hypertension: role of Nox family NADPH oxidases"},{"title3":"The Nox family of NADPH oxidases: friend or foe of the vascular system?"},{"title3":"Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P) H oxidase system"},{"title3":"Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice"},{"title3":"Upregulation of the vascular NAD(P) H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo"},{"title3":"PGC-1alpha limits angiotensin II-induced rat vascular smooth muscle cells proliferation via attenuating NOX1-mediated generation of reactive oxygen species"},{"title3":"ClC-3 promotes angiotensin II-induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation"},{"title3":"Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF"},{"title3":"Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells"},{"title3":"c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells"},{"title3":"Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells"},{"title3":"Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells"},{"title3":"NADPH oxidases and angiotensin II receptor signaling"},{"title3":"Angiotensin II, NADPH oxidase, and redox signaling in the vasculature"},{"title3":"Decreased blood pressure in NOX1-deficient mice"},{"title3":"Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle"},{"title3":"Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice"},{"title3":"Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice"},{"title3":"Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction"},{"title3":"Nox4 genetic inhibition in experimental hypertension and metabolic syndrome"},{"title3":"Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase"},{"title3":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFkappaB signaling pathways"},{"title3":"Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo"},{"title3":"Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice"},{"title3":"NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice"},{"title3":"Endothelial NADPH oxidases: which NOX to target in vascular disease?"},{"title3":"NADPH oxidase 5 is a pro-contractile nox isoform and a point of cross-talk for calcium and redox signaling-implications in vascular function"},{"title3":"NADPH oxidase NOX5 accelerates renal injury in diabetic nephropathy"},{"title3":"Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke"},{"title3":"Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression"},{"title3":"Evidence of the importance of NOX4 in production of hypertension in Dahl salt-sensitive rats"},{"title3":"Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species : studies in white blood cells and in animal models"},{"title3":"Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling"},{"title3":"Mechanisms of oxidative stress in human aortic aneurysms : association with clinical risk factors for atherosclerosis and disease severity"},{"title3":"Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms"},{"title3":"Opportunity NOX: the future of NADPH oxidases as therapeutic targets in cardiovascular disease"},{"title3":"Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein"},{"title3":"Role for Nox1 NADPH oxidase in atherosclerosis"},{"title3":"NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis"},{"title3":"Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice"},{"title3":"Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE-/- mice"},{"title3":"Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling"},{"title3":"The NADPH oxidase Nox4 has anti-atherosclerotic functions"},{"title3":"Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions"},{"title3":"Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells"},{"title3":"Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice"},{"title3":"Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis"},{"title3":"Reactive oxygen species-selective regulation of aortic inflammatory gene expression in type 2 diabetes"},{"title3":"Role of vascular oxidative stress in obesity and metabolic syndrome"},{"title3":"Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function"},{"title3":"VAS2870 is a pan-NADPH oxidase inhibitor"},{"title3":"Enhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice"},{"title3":"Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options"},{"title3":"Vascular ischaemia and reperfusion injury"},{"title3":"NADPH oxidases in cardiovascular disease"},{"title3":"BRG1 regulates NOX gene transcription in endothelial cells and contributes to cardiac ischemia-reperfusion injury"},{"title3":"Cell-specific effects of Nox2 on the acute and chronic response to myocardial infarction"},{"title3":"Elimination of NADPH oxidase activity promotes reductive stress and sensitizes the heart to ischemic injury"},{"title3":"Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor a expression during hypoxia"},{"title3":"Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches"},{"title3":"Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism"},{"title3":"Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy"},{"title3":"Pharmacological postconditioning treatment of myocardial infarction with netrin-1"},{"title3":"Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism"},{"title3":"Central role of SIAH inhibition in DCC-dependent cardioprotection provoked by netrin-1/NO"},{"title3":"Induction of cardioprotection by small netrin-1-derived peptides"},{"title3":"NADPH oxidase-dependent oxidative stress in the failing heart: from pathogenic roles to therapeutic approach"},{"title3":"NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies"},{"title3":"Regulation of myocardial growth and death by NADPH oxidase"},{"title3":"NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis"},{"title3":"Redox signaling in cardiac physiology and pathology"},{"title3":"Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis"},{"title3":"Chemogenetic generation of hydrogen peroxide in the heart induces severe cardiac dysfunction"},{"title3":"Pivotal role of a gp91 phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice"},{"title3":"Activation of NADPH oxidase during progression of cardiac hypertrophy to failure"},{"title3":"Loss of NOX2 (gp91 phox) prevents oxidative stress and progression to advanced heart failure"},{"title3":"Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction"},{"title3":"Acute left ventricular unloading reduces atrial stretch and inhibits atrial arrhythmias"},{"title3":"Role of oxidative stress in cardiac hypertrophy and remodeling"},{"title3":"Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium"},{"title3":"Mitochondrial ROS drive sudden cardiac death and chronic proteome remodeling in heart failure"},{"title3":"Targeting mitochondrial oxidative stress in heart failure throttling the afterburner"},{"title3":"Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure"},{"title3":"Fluorescent protein-based redox probes"},{"title3":"A myocardial Nox2 containing NAD(P) H oxidase contributes to oxidative stress in human atrial fibrillation"},{"title3":"NOX4-dependent hydrogen peroxide overproduction in human atrial fibrillation and HL-1 atrial cells: relationship to hypertension"},{"title3":"Targeting NADPH oxidases in vascular pharmacology"},{"title3":"NOX1, 2, 4, 5: counting out oxidative stress"},{"title3":"The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase"},{"title3":"The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils"},{"title3":"Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils"},{"title3":"Effect of NADPH oxidase inhibition on endothelial cell ELAM-1 mRNA expression"},{"title3":"Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARa mediated mechanism"},{"title3":"Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy"},{"title3":"Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent"},{"title3":"Involvement of phenyl radicals in iodonium inhibition of flavoenzymes"},{"title3":"Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase"},{"title3":"A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells"},{"title3":"The NOX toolbox: validating the role of NADPH oxidases in physiology and disease"},{"title3":"Natural compounds as modulators of NADPH oxidases"},{"title3":"Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms"},{"title3":"Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol"},{"title3":"NADPH oxidase inhibitors: new antihypertensive agents?"},{"title3":"Inhibition of NADPH oxidase by apocynin promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress in rats"},{"title3":"Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets"},{"title3":"Downregulation of neutrophil CD43 by opsonized zymosan"},{"title3":"Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds"},{"title3":"Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids"},{"title3":"S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase"},{"title3":"Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice"},{"title3":"Statins, 3-hydiOxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes"},{"title3":"Cellular antioxidant effects of atorvastatin in vitro and in vivo"},{"title3":"Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium"},{"title3":"Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase"},{"title3":"Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery"},{"title3":"Rational design and characterization of a Rac GTPase-specific small molecule inhibitor"},{"title3":"Inhibition of XO or NOX attenuates diethylstilbestrol-induced endothelial nitric oxide deficiency without affecting its effects on LNCaP cell invasion and apoptosis"},{"title3":"Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation"},{"title3":"Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells"},{"title3":"Comparative pharmacology of chemically distinct NADPH oxidase inhibitors"},{"title3":"A subset of N-substituted phenothiazines inhibits NADPH oxidases"},{"title3":"Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice"},{"title3":"Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma"},{"title3":"Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice"},{"title3":"Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2- and systolic blood pressure in mice"},{"title3":"Nox2 B-looppeptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2"},{"title3":"Selective recapitulation of conserved and nonconserved regions of putative NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase and attenuation of endothelial cell migration"},{"title3":"NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HIS"},{"title3":"First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis"},{"title3":"The novel NADPH oxidase 4 inhibitor GLX351322 counteracts glucose intolerance in high-fat diet-treated C57BL76 mice"},{"title3":"The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro"},{"title3":"Discovery of gsk2795039, a novel small molecule NADPH oxidase 2 inhibitor"},{"title3":"NOX5 in human spermatozoa: expression, function, and regulation"},{"title3":"Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo"},{"title3":"The NOX 1/4 inhibitor GKT 136901 as selective and direct scavenger of peroxynitrite"},{"title3":"Mucosal reactive oxygen species are required for antiviral response: role of Duox in influenza A virus infection"},{"title3":"Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes"},{"title3":"Therapeutic potential of NADPH oxidase 1/4 inhibitors"},{"title3":"NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis"},{"title3":"Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe-/- mice"},{"title3":"A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase"},{"title3":"APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury"},{"title3":"A pan-NADPH oxidase inhibitor ameliorates kidney injury in type 1 diabetic rats"},{"title3":"Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer"},{"title3":"A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies"},{"title3":"Balancing reactive oxygen species in the epigenome: NADPH oxidases as target and perpetrator"},{"title3":"GCN5 regulates the superoxide-generating system in leukocytes via controlling gp91 - phox gene expression"},{"title3":"Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells"},{"title3":"Regulation of oxidative stress in pulmonary artery endothelium: modulation of extracellular superoxide dismutase and NOX4 expression using histone deacetylase class I inhibitors"},{"title3":"Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension"},{"title3":"Epigenetic regulation of vascular NADPH oxidase expression and reactive oxygen species production by histone deacetylase-dependent mechanisms in experimental diabetes"},{"title3":"Epigenetics and regulation of oxidative stress in diabetic retinopathy"},{"title3":"Megakaryocytic leukemia 1 bridges epigenetic activation of NADPH oxidase in macrophages to cardiac ischemia-re perfusion injury"},{"title3":"Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through piOinflammatory effects and endothelial-mesenchymal transition"},{"title3":"Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production"},{"title3":"The p47phox mouse knock-out model of chronic granulomatous disease"}]},{"title2":"Endothelins in cardiovascular biology and therapeutics.","References":[]},{"title2":"Angiotensin-converting enzyme 2 in lung diseases.","References":[{"title3":"A Novel Angiotensin-Converting Enzyme:Related to Angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme: Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters"},{"title3":"The tissue renin-angiotensin system and intracellular signalling"},{"title3":"An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology"},{"title3":"Revisiting the Brain Renin-Angiotensin System:Focus on Novel Therapies"},{"title3":"The ACE2/Angiotensin-(1-7)/Mas axis of the renin-angiotensin system: Focus on Angiotensin-(1-7)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease"},{"title3":"The emerging role of ACE2 in physiology and disease"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney"},{"title3":"Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2/STATs and apoptosis in rat"},{"title3":"Angiotensin II induces apoptosis in human and rat alveolar epithelial cells"},{"title3":"ACE-2/ANG1-7 ameliorates ER stress-induced apoptosis in seawater aspiration-induced acute lung injury"},{"title3":"Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through nuclear factor-kappaB activation in LPS-induced acute lung injury in rats"},{"title3":"Role of renin-angiotensin system in acute lung injury caused by viral infection"},{"title3":"The renin-angiotensin system: Going beyond the classical paradigms"},{"title3":"Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19"},{"title3":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factorkappaB and mitogen-activated protein kinases"},{"title3":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat"},{"title3":"Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats"},{"title3":"Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies"},{"title3":"The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease"},{"title3":"Inflammatory responses and inflammation-associated diseases in organs"},{"title3":"Burying the dead: The impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease"},{"title3":"Autophagy and inflammation in chronic respiratory disease"},{"title3":"Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases"},{"title3":"Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice"},{"title3":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction"},{"title3":"ACE2/Ang1-7 MAS AXIS: The counter-regulator of the classical renin angiotensin system"},{"title3":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD science committee report 2019"},{"title3":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: A systematic analysis for the Global Burden of Disease Study"},{"title3":"An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease"},{"title3":"Chronic obstructive pulmonary disease and comorbidities"},{"title3":"Mouse Mast Cell Protease-4 Deteriorates Renal Function by Contributing to Inflammation and Fibrosis in Immune Complex-Mediated Glomerulonephritis"},{"title3":"The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s)"},{"title3":"Effects of Angiotensin-Converting Enzyme Inhibitors on Spontaneous or Stimulated Generation of Reactive Oxygen Species by Bronchoalveolar Lavage Cells Harvested from Patients with or without Chronic Obstructive Pulmonary Disease"},{"title3":"Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease"},{"title3":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon"},{"title3":"Nicotine and the renin-angiotensin system"},{"title3":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016"},{"title3":"Physiologic similarities and differences between asthma and chronic obstructive pulmonary disease"},{"title3":"CD8+ T cells characterize early smoking-related airway pathology in patients with asthma"},{"title3":"Type 2 inflammation in asthma-present in most, absent in many"},{"title3":"Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells"},{"title3":"Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19"},{"title3":"COVID-19 and Asthma: Reflection During the Pandemic"},{"title3":"Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium"},{"title3":"Managing childhood allergies and immunodeficiencies during respiratory virus epidemics:The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics"},{"title3":"Asthma and COVID-19: Is asthma a risk factor for severe outcomes?"},{"title3":"Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions"},{"title3":"Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation"},{"title3":"Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-kB-dependent pathways"},{"title3":"Severe exacerbations predict excess lung function decline in asthma"},{"title3":"Asthma: Clinical expression and molecular mechanisms"},{"title3":"COVID-19-related genes in sputum cells in asthma: Relationship to demographic features and corticosteroids"},{"title3":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension"},{"title3":"Epidemiology and treatment of pulmonary arterial hypertension"},{"title3":"Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives"},{"title3":"T-helper 17 cell polarization in pulmonary arterial hypertension"},{"title3":"The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)"},{"title3":"Oral delivery of angiotensin-converting enzyme 2 and angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension"},{"title3":"Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/g-protein-coupled mas receptor axis attenuates pulmonary hypertension in ren-2 transgenic rats exposed to chronic hypoxia"},{"title3":"Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats"},{"title3":"ACE2 as therapy for pulmonary arterial hypertension: The good outweighs the bad"},{"title3":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus"},{"title3":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway"},{"title3":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information"},{"title3":"The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer"}]},{"title2":"Angiotensin-converting enzyme 2 protects from severe acute lung failure.","References":[{"title3":"Clinical risks for development of the acute respiratory distress syndrome"},{"title3":"The acute respiratory distress syndrome"},{"title3":"Epidemiology and outcome of acute respiratory failure in intensive care unit patients"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2:a new cardiac regulator"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Avian influenza A (H5N1) in 10 patients in Vietnam"},{"title3":"Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2"},{"title3":"Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome"},{"title3":"Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis"},{"title3":"Male-female differences in fertility and blood pressure in ACE-deficient mice"},{"title3":"Cloning, expression and regulation of angiotensin II receptors"},{"title3":"Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study"},{"title3":"Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia"},{"title3":"Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice"},{"title3":"Consequences of alteration in capillary permeability"},{"title3":"Pulmonary vascular response to angiotensin II in canine pacing-induced heart failure"},{"title3":"PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide"},{"title3":"Hypoxia and angiotensin II infusion redistribute lung blood flow in lambs"},{"title3":"Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome"}]},{"title2":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia.","References":[]},{"title2":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.","References":[{"title3":"Clinical and immunological characteristics of human infections with H5N6 avian influenza virus"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure"},{"title3":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology"},{"title3":"Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease"},{"title3":"The serum profile of hypercytokinemia factors identified in H7N9-infected patients can predict fatal outcomes"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome"},{"title3":"Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Incidence and risk of chronic obstructive pulmonary disease in a Korean community-based cohort"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Effects of calcium channel blockers comparing to angiotensinconverting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumoniarelated outcomes"},{"title3":"An expanded definition of the adult respiratory distress syndrome"},{"title3":"A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice"},{"title3":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure"},{"title3":"Production of angiotensin I converting enzyme inhibitory (ACE-I) peptides during milk fermentation and their role in reducing hypertension"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases Wuhan, China 2019-2020"},{"title3":"Angiotensin blockade in late autosomal dominant polycystic kidney disease"},{"title3":"Hypoalbuminemia in acute illness: is there a rationale for intervention?"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse"},{"title3":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in Wave Five: Clinical and virological findings"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"}]},{"title2":"Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.","References":[{"title3":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010"},{"title3":"Projections of global mortality and burden of disease from 2002 to 2030"},{"title3":"Chronic obstructive pulmonary disease and risk of infection"},{"title3":"Pulmonary infection control window as a switching point for sequential ventilation in the treatment of COPD patients: a meta-analysis"},{"title3":"Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist"},{"title3":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease"},{"title3":"The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study"},{"title3":"Should patients with COPD be vaccinated?"},{"title3":"The association of renin-angiotensin system blockades and pneumonia requiring admission in patients with COPD"},{"title3":"Angiotensin receptor subtype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II"},{"title3":"Angiotensin II type 1 receptor blocker inhibits pulmonary injury"},{"title3":"Pneumonia risk and use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers"},{"title3":"Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis"},{"title3":"Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury"},{"title3":"Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes"},{"title3":"The association of cardioprotective medications with pneumonia-related outcomes"},{"title3":"Risk of pneumonia in patients with gastroesophageal reflux disease: a population-based cohort study"},{"title3":"Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist"},{"title3":"Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis"},{"title3":"Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation"}]},{"title2":"Hypertension: renin-angiotensin-aldosterone system alterations.","References":[]},{"title2":"Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC Randomized Clinical Trial.","References":[]},{"title2":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.","References":[]},{"title2":"Antimicrobial resistance in nephrology.","References":[{"title3":"Tackling drug-resistant infections globally: final report and recommendations"},{"title3":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance"},{"title3":"US Renal Data System 2017 Annual Data Report: epidemiology of kidney disease in the United States"},{"title3":"Multidrug-resistant organisms in dialysis patients"},{"title3":"Molecular mechanisms of antibiotic resistance"},{"title3":"Infection by penicillin-resistant staphylococci"},{"title3":"Methicillin-resistant staphylococci"},{"title3":"Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics"},{"title3":"Community-associated meticillin-resistant Staphylococcus aureus"},{"title3":"International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: device-associated module"},{"title3":"Meta-analysis of methicillin-resistant Staphylococcus aureus colonization and risk of infection in dialysis patients"},{"title3":"Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members"},{"title3":"Invasive methicillin-resistant Staphylococcus aureus infections among chronic dialysis patients in the United States, 2005-2011"},{"title3":"Carriage frequency, phenotypic and genotypic characteristics of Staphylococcus aureus isolated from dialysis and kidney tranplant patients at a hosptial in northern Parana"},{"title3":"Colonisation with methicillin-resistant Staphylococcus aureus prior to renal transplantation is associated with long-term renal allograft failure"},{"title3":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility"},{"title3":"Systematic review and meta-analysis of the epidemiology of vancomycin-intermediate and heterogeneous vancomycin-intermediate Staphylococcus aureus isolates"},{"title3":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance"},{"title3":"Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus"},{"title3":"The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA"},{"title3":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group"},{"title3":"Staphylococcus aureus resistant to vancomycin:-United States, 2002"},{"title3":"Vancomycin-resistant Staphylococcus aureus -Delaware, 2015"},{"title3":"First case of infection with vancomycin-resistant Staphylococcus aureus in Europe"},{"title3":"Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains"},{"title3":"The life and times of the Enterococcus"},{"title3":"Antibiotic resistance in Staphylococcus aureus. Current status and future prospects"},{"title3":"Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance"},{"title3":"Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients"},{"title3":"National Healthcare Safety Network (NHSN) Dialysis Event Surveillance Report for 2014"},{"title3":"Risk factors and outcomes associated with acquisition of daptomycin and linezolid-nonsusceptible vancomycin-resistant Enterococcus"},{"title3":"Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis"},{"title3":"Surveillance for linezolid resistance via the Zyvox  Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates"},{"title3":"Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012)"},{"title3":"Emergence of daptomycin-resistant VRE: experience of a single institution"},{"title3":"Mechanisms of drug resistance: daptomycin resistance"},{"title3":"De novo daptomycin-nonsusceptible enterococcal infections"},{"title3":"Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis"},{"title3":"Returning to the pre-antibiotic era in the critically ill: the XDR problem"},{"title3":"&quot;Stormy waters ahead&quot;: global emergence of carbapenemases"},{"title3":"Occurrence of clinically important lineages, including the sequence type 131 C1-M27 subclone, among extended-spectrum-beta-lactamase-producing Escherichia coli in wastewater"},{"title3":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study"},{"title3":"Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta-lactamase and carbapenemase-producing pathogens"},{"title3":"Effect of piperacillin-tazobactam versus meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance"},{"title3":"The ecology of extended-spectrum beta-lactamases (ESBLs) in the developed world"},{"title3":"AmpC beta-lactamases"},{"title3":"Epidemiology and risk factors for infections due to AmpC beta-lactamase-producing Escherichia coli"},{"title3":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae"},{"title3":"Transferable imipenem resistance in Pseudomonas aeruginosa"},{"title3":"Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance"},{"title3":"The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace"},{"title3":"Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms -United States, 2006-2017"},{"title3":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014"},{"title3":"Mechanism of quinolone action and resistance"},{"title3":"Antimicrobial resistance of Escherichia coli urinary isolates in the Veterans Affairs Health Care System"},{"title3":"Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases"},{"title3":"EUCAST expert rules in antimicrobial susceptibility testing"},{"title3":"Association between the presence of aminoglycoside-modifying enzymes and in vitro activity of gentamicin, tobramycin, amikacin, and plazomicin against Klebsiella pneumoniae carbapenemase-and extended-spectrum-beta-lactamase-producing Enterobacter species"},{"title3":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015"},{"title3":"Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality"},{"title3":"Molecular mechanisms of polymyxin resistance: knowns and unknowns"},{"title3":"Epidemiology of infections caused by polymyxin-resistant pathogens"},{"title3":"How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals?"},{"title3":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies"},{"title3":"Emergence of antimicrobial resistance to Pseudomonas aeruginosa in the intensive care unit: association with the duration of antibiotic exposure and mode of administration"},{"title3":"Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges"},{"title3":"Acinetobacter: an old friend, but a new enemy"},{"title3":"Multidrug-resistant Acinetobacter baumannii in New York City -10 years into the epidemic"},{"title3":"Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014"},{"title3":"Completeness of methicillin-resistant Staphylococcus aureus bloodstream infection reporting from outpatient hemodialysis facilities to the National Healthcare Safety Network, 2013"},{"title3":"Risk and prognosis of bloodstream infections among patients on chronic hemodialysis: a population-based cohort study"},{"title3":"Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis"},{"title3":"Hemodialysis catheter-related infection: rates, risk factors and pathogens"},{"title3":"Epidemiology of infections and antimicrobial use in Australian haemodialysis outpatients: findings from a Victorian surveillance network, 2008-2015"},{"title3":"Peritoneal dialysis associated infections: an update on diagnosis and management"},{"title3":"Microbiology and outcomes of peritonitis in northern India"},{"title3":"Effects of a statewide protocol for the management of peritoneal dialysis-related peritonitis on microbial profiles and antimicrobial susceptibilities: a retrospective five-year review"},{"title3":"Microbiological surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in GERMANY over 32 years"},{"title3":"Infection in organ transplantation"},{"title3":"Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations"},{"title3":"Urinary tract infections in kidney transplant recipients: role of gender, urologic abnormalities, and antimicrobial prophylaxis"},{"title3":"Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers"},{"title3":"Urinary tract infections following renal transplantation"},{"title3":"Multidrug-resistant bacteria in solid organ transplant recipients"},{"title3":"Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients"},{"title3":"AST Infectious Diseases Community of Practice. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation"},{"title3":"Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation"},{"title3":"Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients"},{"title3":"Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients"},{"title3":"Carbapenem-resistant Enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies"},{"title3":"Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies"},{"title3":"Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections"},{"title3":"Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model"},{"title3":"Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U. S. hospitals, 2008 to 2011"},{"title3":"Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: report from an Antimicrobial Surveillance Program (2013-2015)"},{"title3":"Ceftolozane/tazobactam activity tested against aerobic gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)"},{"title3":"Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI)"},{"title3":"Ceftolozane-tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa infections: clinical effectiveness and evolution of resistance"},{"title3":"Multicenter evaluation of ceftolozane/tazobactam for serious infections caused by carbapenem-resistant Pseudomonas aeruginosa"},{"title3":"Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections"},{"title3":"Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study"},{"title3":"Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program"},{"title3":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae"},{"title3":"Meropenem-vaborbactam tested against contemporary gram-negative isolates collected worldwide during 2014, including carbapenem-resistant, KPC-producing, multidrug-resistant, and extensively drug-resistant Enterobacteriaceae"},{"title3":"Effect of meropenem-vaborbactam versus piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I randomized clinical trial"},{"title3":"Effect and safety of meropenem-vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial"},{"title3":"Telavancin activity in vitro tested against a worldwide collection of gram-positive clinical isolates (2014)"},{"title3":"Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-2016)"},{"title3":"Dalbavancin: a novel lipoglycopeptide antibiotic with extended activity against gram-positive infections"},{"title3":"Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens"},{"title3":"Activity of plazomicin against gram-negative and gram-positive isolates collected from U. S. hospitals and comparative activities of aminoglycosides against carbapenem-resistant enterobacteriaceae and isolates carrying carbapenemase genes"},{"title3":"Teaching an old class new tricks: a novel semi-synthetic aminoglycoside, plazomicin"},{"title3":"A multicenter, randomized, double-blind, phase 2 study of the efficacy and safety of plazomicin compared with levofloxacin in the treatment of complicated urinary tract infection and acute pyelonephritis"},{"title3":"Review of eravacycline, a novel fluorocycline antibacterial agent"},{"title3":"In vitro susceptibility of beta-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE) to eravacycline"},{"title3":"Assessing the efficacy and safety of eravacycline versus ertapenem in complicated intra-abdominal infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) trial: a randomized clinical trial"},{"title3":"A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study"},{"title3":"Recommendations for preventing transmission of infections among chronic hemodialysis patients"},{"title3":"Hemodialysis and water quality"},{"title3":"Serratia marcescens bacteraemia outbreak in haemodialysis patients with tunnelled catheters due to colonisation of antiseptic solution. Experience at 4 hospitals"},{"title3":"Hemodialyzer reuse and gram-negative bloodstream infections"},{"title3":"Survey of infection control practices in hemodialysis units: preventing vascular access-associated bloodstream infections"},{"title3":"Variation in infection prevention practices in dialysis facilities: results from the national opportunity to improve infection control in ESRD (End-Stage Renal Disease) project"},{"title3":"Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: a quality improvement report"},{"title3":"Sustained infection reduction in outpatient hemodialysis centers participating in a collaborative bloodstream infection prevention effort"},{"title3":"Reducing healthcare-associated infections in an ambulatory dialysis unit: identification and alignment of work system factors"},{"title3":"Factors associated with the receipt of antimicrobials among chronic hemodialysis patients"},{"title3":"Fistula first breakthrough initiative: targeting catheter last in fistula first"},{"title3":"Approaches for preventing healthcare-associated infections: go long or go wide?"},{"title3":"Antimicrobial use in outpatient hemodialysis units"},{"title3":"Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study"},{"title3":"Antimicrobial stewardship programs in inpatient hospital settings: a systematic review"},{"title3":"Clinical and economic benefits of antimicrobial stewardship programs in hemodialysis facilities: a decision analytic model. Clin"},{"title3":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America"},{"title3":"Implementing an antimicrobial stewardship program in out-patient dialysis units"},{"title3":"Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus: a systematic review and meta-analysis"},{"title3":"Screening and treatment for Staphylococcus aureus in patients undergoing hemodialysis: a systematic review and meta-analysis"},{"title3":"Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment"},{"title3":"A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage"},{"title3":"Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit"},{"title3":"Intestinal decolonization of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature"},{"title3":"Alternatives to antibiotics-a pipeline portfolio review"},{"title3":"Development of phage lysins as novel therapeutics: a historical perspective"},{"title3":"Chemotherapy with phage lysins reduces pneumococcal colonization of the respiratory tract"},{"title3":"Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme"},{"title3":"An ointment consisting of the phage lysin LysGH15 and apigenin for decolonization of methicillin-resistant Staphylococcus aureus from skin wounds"},{"title3":"Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia"},{"title3":"Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model"},{"title3":"Human commensals producing a novel antibiotic impair pathogen colonization"},{"title3":"Bioprospecting deep-sea actinobacteria for novel anti-infective natural products"},{"title3":"Effects of vaccination on invasive pneumococcal disease in South Africa"},{"title3":"A population-based assessment of the impact of 7-and 13-valent pneumococcal conjugate vaccines on macrolide-resistant invasive pneumococcal disease: emergence and decline of Streptococcus pneumoniae serotype 19A (CC320) with dual macrolide resistance mechanisms"},{"title3":"Deploy vaccines to fight superbugs"},{"title3":"Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: phase III randomized study"},{"title3":"Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis"},{"title3":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial"},{"title3":"SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies"},{"title3":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults"},{"title3":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind, placebo-controlled trial"},{"title3":"Gleaning insights from fecal microbiota transplantation and probiotic studies for the rational design of combination microbial therapies"},{"title3":"Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection"},{"title3":"Reduction of antibiotic resistance genes in intestinal microbiota of patients with recurrent Clostridium difficile infection after fecal microbiota transplantation"},{"title3":"Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation for recurrent Clostridium difficile infection"},{"title3":"Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review"},{"title3":"Fecal microbiota transplantation against intestinal colonization by extended spectrum beta-lactamase producing enterobacteriaceae: a proof of principle study"},{"title3":"Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study"},{"title3":"A secreted bacterial peptidoglycan hydrolase enhances tolerance to enteric pathogens"}]}]}]}